MIRA INFORM REPORT

Report Date :

11.05.2012

IDENTIFICATION DETAILS

Name :	SANOFI CHIMIE

Registered Office :	9 Rue Du Pdt Salvador Allende, 94250 Gentilly

Country :	France

Financials (as on) :	31.12.2010

Date of Incorporation :	December 1999

Com. Reg. No.:	RCS Creteil 0 428 706 204

Legal Form :	Public limited company with board of directors

Line of Business :	Manufacturer of basic pharmaceutical products

No. of Employees :	2 000 to 4 999

RATING & COMMENTS

MIRA’s Rating :

RATING		STATUS	PROPOSED CREDIT LINE
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large

Status :	Good
Payment Behaviour :	No Complaints
Litigation :	Clear

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31^st, 2012

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

France

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

REGISTERED NAME & COMPANY SUMMARY

SANOFI CHIMIE

company summary


Activity (APE)	Fabrication de produits pharmaceutiques de base (2110Z) (Manufacture of basic pharmaceutical products (2110Z))	Legal form	Public limited company with board of directors
Phone	01 41 24 70 00	RCS Registration	RCS Creteil 0 428 706 204
Fax		Share capital	524,786,320 Euros
Address	SANOFI CHIMIE 9 RUE DU PDT SALVADOR ALLENDE 94250 GENTILLY	Incorporated Date	12/1999
Nationality	France	Status	Economically active
Branch	45 Chemin De Meteline 04201 Sisteron

Company details

Activity (APE)		Fabrication de produits pharmaceutiques de base (2110Z) (Manufacture of basic pharmaceutical products (2110Z)))
RCS Registration		RCS Creteil 0 428 706 204	Share capital	524,786,320 Euros
Registration Court		Creteil (94)	Legal form	Public limited company with board of directors
Court Registry Number		20 0 2B005	EU VAT Number	FR86428706204
Incorporation Date		12/1999	Formation Date	12/1999
Deregistration Date			Last account Date	31/12/2010
Nationality	France

Ultimate Parent

1 ultimate parent company for this company
> SANOFI - Activités des sièges sociaux (7010Z) in PARIS 8 (75008)

Establishment details

Activity (APE)	Activités des sièges sociaux (7010Z)	Business Pages FT®
Postal Address	SANOFI CHIMIE 9 RUE DU PDT SALVADOR ALLENDE 94250 GENTILLY	Trading Address	9 RUE DU PDT SALVADOR ALLENDE 94250 GENTILLY
Telephone	01 41 24 70 00
Fax

Type	Head office	Status	Economically active
Formation Date	12/2001	Reason for formation	Other
Closure Date		Reason for closure
Reactivation Date		Production Role
Activity Nature	-	Activity Location	Other
Location surface		Seasonality

Department	Val-de-Marne (94)	Region	Ile-de-France
District	3	Area	87
City	GENTILLY	Size of urban area	Paris conglomeration

Other establishments

	Branches	11 branch entities in this company
	Head office	> SANOFI CHIMIE <<< - Fabrication de produits pharmaceutiques de base (2110Z) in GENTILLY (94250)
	Secondary establishments	> SANOFI CHIMIE - Fabrication de produits pharmaceutiques de base (2110Z) in PLOERMEL (56800) > SANOFI CHIMIE - Fabrication de produits pharmaceutiques de base (2110Z) in SISTERON (04200) > SANOFI CHIMIE - Fabrication de produits pharmaceutiques de base (2110Z) in GENTILLY (94250) > SANOFI CHIMIE - Fabrication de produits pharmaceutiques de base (2110Z) in ARAMON (30390) > ...

	Regionality	Legal unit with multiple establishments in many areas but no one grouping more than 50% of workforce
	Mono-activity status	Legal unit with multiple establishments having main activities in many divisions, which one activity grouping from 80 to 99% of workforce

Workforces

Workforce at address

Workforce unknown

Company workforce

2 000 to 4 999 employees

DIRECTORS/MANAGEMENT

directors

Shareholder(s)

Name	SANOFI WINTHROP INDUSTRIE
Name of representative	M LUSCAN PHILIPPE
Manager position	Administrateur	Date of birth	03/04/1962
Place of birth	PAU
Type of manager	Moral person	Name at birth of manager

Name	SANOFI-AVENTIS GROUPE
Name of representative	M LHERNOULD GILLES
Manager position	Administrateur	Date of birth	09/10/1955
Place of birth	PARIS
Type of manager	Moral person	Name at birth of manager

Name	SANOFI-AVENTIS PARTICIPATIONS
Name of representative	M TOURATIER GÉRARD
Manager position	Administrateur	Date of birth	31/07/1951
Place of birth	BOIS COLOMBES
Type of manager	Moral person	Name at birth of manager

Name	M. CARRE FRANCIS
Manager position	Président Directeur Général, Administrateur	Date of birth	02/01/1953
Place of birth	CAUDERAN
Type of manager	Individual	Name at birth of manager

Name	M. BROM JACQUES
Manager position	Directeur général délégué	Date of birth	20/04/1965
Place of birth	MULHOUSE
Type of manager	Individual	Name at birth of manager


Name	Mme. DUPONT-CAYRON MARIE-CLAIRE
Manager position	Directeur général délégué	Date of birth	17/03/1960
Place of birth	RODEZ
Type of manager	Individual	Name at birth of manager	CAYRON

Previous Directors

Vous pouvez consulter ici l'historique des dirigeants de l'entreprise.
Si vous souhaitez consulter l'historique d'un dirigeant, il vous suffit de cliquer sur le lien voir le détail pour y accéder.

Manager position	Title and name	Date of Birth/Place of Birth
Président du conseil d'administration	M PHILIPPE LUSCAN
Président du conseil d'administration	M PHILIPPE LUSCAN
Président Directeur Général	M FRANCIS CARRE
Président Directeur Général	M FRANCIS CARRE
Directeur général	M PHILIPPE LUSCAN
Directeur général	M PHILIPPE LUSCAN
Directeur général	M ALAIN RAMET
Directeur général délégué	MME MARIE-CLAIRE CAYRON
Directeur général délégué	MME MARIE-CLAIRE DUPONT CAYRON
Directeur général délégué	MME MARIE-CLAIRE DUPONT CAYRON
Directeur général délégué	Mme MARIE-CLAIRE DUPONT-CAYRON
Directeur général délégué	M DOMINIQUE EVEN
Directeur général délégué	M DOMINIQUE EVEN
Administrateur	M FRANCIS CARRE
Administrateur	M FRANCIS CARRE
Administrateur	M JEAN-PIERRE LEHNER
Administrateur	SANOFI AVENTIS GROUPE
Administrateur	SANOFI AVENTIS PARTICIPATIONS
Administrateur	SANOFI WINTHROP INDUSTRIE
Administrateur	SANOFI WINTHROP INDUSTRIE
Administrateur	SANOFI-AVENTIS GROUPE
Administrateur	SANOFI-AVENTIS PARTICIPATIONS

NEGATIVE INFORMATION

judgements

Collective procedures

No judgment information for the company

SHARE & SHARE CAPITAL INFORMATION

Share capital

524,786,320 Euros

PAYMENT INFORMATION

GROUP STRUCTURE & AFFILIATED COMPANIES

Ultimate Holding Company
	Company Name	Company number
	SANOFI	395030844

Group data

Ultimate parent company	SANOFI
Direct parent	SANOFI-AVENTIS PARTICIPATIONS SAS - 100 %
Group – Number of companies	295
Linkages – Number of companies	174
Number of countries	28

Go directly to the current company

Raison sociale		SIREN		Parts		Score		Limite		Derniers comptes publiés
SANOFI	395030844		-		100		250 000 €		31/12/2010
AVENTIS PHARMA S.A	304463284		100%		100		2 000 000 €		31/12/2010
SANOFI-AVENTIS CANADA INC	-		100%		-		-		-
AVENTIS PHARMA LTD JAPAN	-		100%		-		-		-
AVENTIS PHARMA SPA	-		100%		-		-		-
BIOCITECH SAS	487772527		100%		94		390 000 €		31/12/2010
SANOFI-AVENTIS PARTICIPATIONS	440646982		44%		92		250 000 €		31/12/2010
QUIMICA MEDICAL SA	-		100%		-		-		-
SANOFI PARTICIPATIONS	407571728		100%		99		250 000 €		31/12/2010
SANOFI PHARMA BRISTOL-MYERS SQ...	408017929		50.10%		100		2 000 000 €		31/12/2010
SANOFI WINTHROP BRISTOL-MYERS ...	24278674		50.10%		69		4 500 €		-
WINTHROP MEDICAMENTS	407710474		99.88%		95		150 000 €		31/12/2010
SANOFI AVENTIS DE MEXICO SA DE CV	-		100%		-		-		-
LABORATORIOS KENDRICK	-		100%		-		-		-
SANOFI AVENTIS PARAGUAY SA	-		99.99%		-		-		-
SANOFI-AVENTIS DE PANAMA SA	-		100%		-		-		-
SANOFI AVENTIS GMBH	-		100%		-		-		-
SANOFI SYNTHÉLABO ILAC AS	-		100%		-		-		-
SANOFI AVENTIS DE GUATEMALA SA	-		100%		-		-		-
SANOFI-AVENTIS PRODUCTOS FARMACEUTICOS L...	-		39.46%		-		-		-
SANOFI AVENTIS TAIWAN CO LTD	-		100%		-		-		-
SANOFI AVENTIS TUNISIE	-		99.90%		-		-		-
SANOFI DEVELOPPEMENT PHARMA	401393624		100%		100		250 000 €		31/12/2010
SANOFI-AVENTIS (HANGZHOU) PHARMACEUTICAL...	-		100%		-		-		-
SANOFI AVENTIS PHILIPPINES INC	-		100%		-		-		-
SANOFI-AVENTIS DEL ECUADOR SA	-		100%		-		-		-
SANOFI AVENTIS PHARMA TUNISIE	-		100%		-		-		-
SANOFI-AVENTIS FRANCE	403335904		100%		96		2 000 000 €		31/12/2010
SANOFI-AVENTIS YAMANOUCHI PHARMACEUTICAL...	-		51%		-		-		-
SANOFI-AVENTIS DE VÉNÉZUELA SA	-		100%		-		-		-
SANOFI-AVENTIS CONSUMER HEALTHCARE NEW Z...	-		100%		-		-		-
SANOFI AVENTIS URUGUAY SA	-		100%		-		-		-
BIOCITECH SERVICE	410512206		100%		98		500 €		31/12/2010
SANOFI AVENTIS FARMACEUTICA LTDA	-		100%		-		-		-
SANOFI AVENTIS MAROC	-		100%		-		-		-
SANOFI AVENTIS DOO	-		100%		-		-		-
FUJISAWA SANOFI AVENTIS KK	-		51%		-		-		-
SANOFI-AVENTIS AB	5564412574		100%		84		50 000 KSEK		31/12/2010
SANOFI AVENTIS LIBAN SAL	-		100%		-		-		-
SANOFI AVENTIS HONG KONG LIMITED	-		100%		-		-		-
SANOFI SYNTHELABO KENYA LTD	-		100%		-		-		-
WINTHROP PHARMACEUTICALS DE MEXICO SA DE...	-		100%		-		-		-
SANOFI AVENTIS PHARMA SLOVAKIA SRO	-		100%		-		-		-
SANOFI-AVENTIS DEL PÉRU SA	-		100%		-		-		-
SANOFI PASTEUR	-		100%		-		-		-

SANOFI AVENTIS SPA					-				100%				-		-				-
	SANOFI AVENTIS AUSTRALIA PTY LIMITED			-				100%				-		-			-
	SANOFI SYNTHÉLABO (MALAYSIA) SDN-BHD			-				100%				-		-			-
	AVENTIS PHARMA LTD			-				100%				-		-			-
	SANOFI PHARMA DE MEXICO SA DE CV			-				100%				-		-			-
	SANOFI WINTHROP INDUSTRIE			775662257				100%				100		2 000 000 €			31/12/2010
	PT AVENTIS PHARMA			-				75%				-		-			-
	SPI			388821043				100%				100		250 000 €			31/12/2010
	SANOFI-SYNTHÉLABO VIETNAM PHARMACEUTICAL...			-				70%				-		-			-
	SANOFI-AVENTIS SRO			-				100%				-		-			-
	SANOFI AVENTIS OY			-				100%				-		-			-
	SANOFI-AVENTIS ARGENTINA SA			-				100%				-		-			-
	SANOFI-AVENTIS BELGIUM NV			464435901				100%				95		10 800 000 €			31/12/2010
	SANOFI-AVENTIS RECHERCHE DEVELOP...			713002269				95.46%				100		2 000 000 €			31/12/2010
	SANOFI AVENTIS NETHERLAND BV			-				100%				-		-			-
	SANOFI-SYNTHELABO UK LIMITED			00692858				100%				69		2 500 000 £			31/12/2010
	SANOFI AVENTIS SINGAPORE PTE LTD			-				100%				-		-			-
	SYNTHELABO TANABE CHIMIE			340723022				50%				100		270 000 €			31/12/2010
	SANOFI AVENTIS KK			-				100%				-		-			-
	SANOFI SYNTHÉLABO MAROC			-				99.99%				-		-			-
	SANOFI AVENTIS SA			-				100%				-		-			-
	SANOFI AVENTIS DENMARK A/S			-				100%				-		-			-
	SANOFI AVENTIS GULF FZE			-				100%				-		-			-
	SANOFI CHIMIE			428706204				100%				89		2 000 000 €			31/12/2010
	FRANCOPIA			775662463				100%				72		2 000 000 €			31/12/2010
	ALCALIBER SA			-				40%				-		-			-
	SANOFI-AVENTIS AEBE GREECE			-				100%				-		-			-
	SANOFI-SYNTHÉLABO (THAILAND) LTD			-				100%				-		-			-
	PT SANOFI AVENTIS INDONESIA			-				100%				-		-			-
	SANOFI AVENTIS AFC (CAMEROUN)			-				100%				-		-			-
	SANOFI AVENTIS (SUISSE) SA			-				100%				-		-			-
	SANOFI-AVENTIS VIETNAM CO. LTD			-				100%				-		-			-
	SANOFI-SYNTHÉLABO SLOVAKIA S.R.O.			-				100%				-		-			-
	PMC 2			414896696				100%				96		550 €			31/12/2010
AVENTIS PHARMA SPAIN SA			-				100%				-					-		-
	AVENTIS PHARMA UK INVESTMENTS LTD	-				100%				-					-		-
	SANOFI-AVENTIS DE COLOMBIA SA	-				90%				-					-		-
	SANOFI-AVENTIS DE CHILE SA	-				100%				-					-		-
	GROUPEMENT DE FABRICATION PHARMACEUT...	383960598				100%				100					55 000 €		31/12/2010
	WINTHROP PHARMACEUTICALS DE COLOMBIA SA	-				100%				-					-		-
	SANOFI AVENTIS IRELAND LTD	-				100%				-					-		-
	SANOFI A.O.	-				100%				-					-		-
	SANOFI-AVENTIS EUROPE	408373959				100%				100					250 000 €		31/12/2010
	SANOFI-AVENTIS PRODUCTOS FARMACEUTICOS L...	-				46.90%				-					-		-
	ZENTIVA	-				99.10%				-					-		-
	HOECHST GMBH	HRB 75707				100%				70					5 900 000 €		31/12/2010
	SANOFI SA/AG	-				100%				-					-		-
	AVENTIS INC	484786629				100%				-					-		-
	CHINOIN PRIVATE CO LTD	-				99.60%				-					-		-
	SANOFI AVENTIS ROMANIA	-				100%				-					-		-
	AVENTIS PHARMA MANUFACTURING PTE LTD	-				100%				-					-		-
	SANOFI PASTEUR LIMITED	-				100%				-					-		-
	SANOFI WINTHROP BMS OY	-				50.10%				-					-		-
	WINTHROP PHARMA SAÏDAL S.P.A.	-				70%				-					-		-
	SANOFI-AVENTIS GROUPE	403335938				100%				100					2 000 000 €		31/12/2010
	WINTHROP ILAC ANONIM SIRKETI	-				100%				-					-		-
	WINTHROP PHARMACEUTICALS UK LIMITED	02158996				100%				98					415 000 £		31/12/2010
	SANOFI-AVENTIS GMBH / BRISTOL-MYERS SQUI...	-				50.10%				-					-		-
	CARDERM CAPITAL LP	-				100%				-					-		-
	SANOFI-AVENTIS NORGE AS	976335147				100%				91					2 040 000 €		31/12/2010
	SANOFI SYNTHÉLABO REC	-				100%				-					-		-
	SANOFI-AVENTIS EGYPT SAE	-				100%				-					-		-
	SANOFI-AVENTIS US LLC	-				100%				-					-		-
	SANOFI-AVENTIS DE LA RÉPUBLICA DOMINICAN...	-				100%				-					-		-
	WINTHROP ARZNEIMITTEL GMBH	HRB 14056				100%				65					510 000 €		31/12/2010
	BRISTOL MYERS SQUIBB/ SANOFI-SYNTHÉLABO ...	-				49.90%				-					-		-
	SANOFI SYNTHÉLABO BMS ADI ORTAKLIGI PART...	-				50.10%				-					-		-
	SANOFI-AVENTIS (CHINA) INVESTMENTS	-				100%				-					-		-
	SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD	-				100%				-					-		-
	SANOFI SYNTHÉLABO INDIA LTD	-				100%				-					-		-
	FUJISAWA SANOFI-SYNTHÉLABO PHARMACEUTICA...	-				51%				-					-		-
	AVENTIS AGRICULTURE	352704746				100%				95					710 000 €		31/12/2010
	AVENTIS ANIMAL NUTRITION SA	915850283				100%				98					22 000 €		31/12/2010
	SANOFI 4	493370258				99.99%				100					250 000 €		31/12/2010
	MERIAL INTERNATIONAL LIMITED	02725013				100%				No Rating					-		28/02/2005
	MERIAL CANADA INC.	-				100%				-					-		-
	MERIAL IA LLP	-				100%				-					-		-
	MERIAL	590800215				100%				100					2 000 000 €		31/12/2010
	MERIAL BELGIUM SA	445411231				100%				95					255 000 €		31/12/2010
	MERIAL NEW ZEALAND LIMITED	-				100%				-					-		-
	MERIAL B.V.	33224075				100%				52					240 000 €		31/12/2010

MERIAL NORDEN A/S			-		100%		-		-		-
	MERIAL ANIMAL HEALTH CO. LTD	-		99%		-		-		-
	MERIAL THAILAND LTD	-		99%		-		-		-
	MERIAL JAPAN LTD	-		80%		-		-		-
	MERIAL COLOMBIA SA	-		94.20%		-		-		-
	MERIAL NANJING ANIMAL HEALTH CO. LTD	-		50%		-		-		-
	MERIAL TAIWAN CO. LTD	-		100%		-		-		-
	MERIAL AUSTRALIA PTY LTD	-		100%		-		-		-
	MERIAL ITALIA SPA	-		100%		-		-		-
	MERIAL SA	-		100%		-		-		-
	MERIAL SAUDE ANIMAL LIMITADA	-		100%		-		-		-
	MERIAL LABORATORIOS SA	-		100%		-		-		-
	MERIAL INC	-		100%		-		-		-
	MERIAL GMBH	HRB 118923		100%		79		380 000 €		31/12/2010
	MERIAL ANIMAL HEALTH LIMITED	01961886		100%		95		560 000 £		31/12/2010
	MERIAL MEXICO SA DE CV	-		100%		-		-		-
	COOPERATION PHARMACEUTIQUE V...	066200890		100%		100		750 000 €		31/12/2010
	MERIAL PORTUGUESA SAUDE ANIMAL LDA	-		100%		-		-		-
	MERIAL ASIA PRIVATE LIMITED	-		100%		-		-		-
	MERIAL SOUTH AFRICA (PTY) LTD	-		100%		-		-		-
	BEIJING MERIAL VITAL LABORATORY ANIMAL T...	-		75%		-		-		-
	ANCARE	-		Majoritaire		-		-		-
	MERIAL DISTRIBUTION	451279640		100%		100		1 400 €		31/12/2010
	MERIAL ARGENTINA SA	-		100%		-		-		-
	MERIAL INTERNATIONAL TRADING (SHANGHAI) ...	-		100%		-		-		-
	MERIAL PHILIPPINES INC	-		100%		-		-		-
	MERIAL SELECT INC	-		100%		-		-		-
	MERIAL KOREA LTD	-		100%		-		-		-
	MERIAL VACCINATION TECHNOLOGIES INC	-		100%		-		-		-
	ANCARE AUSTRALIA (PTY) LIMITED	-		100%		-		-		-
	ANCARE IRELAND LIMITED	-		100%		-		-		-
	ANIMAL HEALTH CARE SOUTH AFRICA (PTY) LI...	-		100%		-		-		-
	NEWPORT LABORATORIES	-		Majoritaire		-		-		-
	MERIAL INDIA PRIVATE LIMITED	-		100%		-		-		-
	SANOFI-AVENTIS PARTICIPATIONS	440646982		56%		92		250 000 €		31/12/2010
	QUIMICA MEDICAL SA	-		100%		-		-		-
	SANOFI PARTICIPATIONS	407571728		100%		99		250 000 €		31/12/2010
	SANOFI PHARMA BRISTOL-MYERS SQUI...	408017929		50.10%		100		2 000 000 €		31/12/2010
	SANOFI WINTHROP BRISTOL-MYERS SQ...	24278674		50.10%		69		4 500 €		-
	WINTHROP MEDICAMENTS	407710474		99.88%		95		150 000 €		31/12/2010
	SANOFI AVENTIS DE MEXICO SA DE CV	-		100%		-		-		-
	LABORATORIOS KENDRICK	-		100%		-		-		-
	SANOFI AVENTIS PARAGUAY SA	-		99.99%		-		-		-
	SANOFI-AVENTIS DE PANAMA SA	-		100%		-		-		-
	SANOFI AVENTIS GMBH	-		100%		-		-		-
	SANOFI SYNTHÉLABO ILAC AS	-		100%		-		-		-
	SANOFI AVENTIS DE GUATEMALA SA	-		100%		-		-		-
	SANOFI-AVENTIS PRODUCTOS FARMACEUTICOS L...	-		39.46%		-		-		-
	SANOFI AVENTIS TAIWAN CO LTD	-		100%		-		-		-
	SANOFI AVENTIS TUNISIE	-		99.90%		-		-		-
	SANOFI DEVELOPPEMENT PHARMA	401393624		100%		100		250 000 €		31/12/2010

SANOFI-AVENTIS (HANGZHOU) PHARMACEUTICAL...		-		100%		-		-		-
	SANOFI AVENTIS PHILIPPINES INC		-		100%		-		-		-
	SANOFI-AVENTIS DEL ECUADOR SA		-		100%		-		-		-
	SANOFI AVENTIS PHARMA TUNISIE		-		100%		-		-		-
	SANOFI-AVENTIS FRANCE		403335904		100%		96		2 000 000 €		31/12/2010
	SANOFI-AVENTIS YAMANOUCHI PHARMACEUTICAL...		-		51%		-		-		-
	SANOFI-AVENTIS DE VÉNÉZUELA SA		-		100%		-		-		-
	SANOFI-AVENTIS CONSUMER HEALTHCARE NEW Z...		-		100%		-		-		-
	SANOFI AVENTIS URUGUAY SA		-		100%		-		-		-
	BIOCITECH SERVICE		410512206		100%		98		500 €		31/12/2010
	SANOFI AVENTIS FARMACEUTICA LTDA		-		100%		-		-		-
	SANOFI AVENTIS MAROC		-		100%		-		-		-
	SANOFI AVENTIS DOO		-		100%		-		-		-
	FUJISAWA SANOFI AVENTIS KK		-		51%		-		-		-
	SANOFI-AVENTIS AB		5564412574		100%		84		50 000 KSEK		31/12/2010
	SANOFI AVENTIS LIBAN SAL		-		100%		-		-		-
	SANOFI AVENTIS HONG KONG LIMITED		-		100%		-		-		-
	SANOFI SYNTHELABO KENYA LTD		-		100%		-		-		-
	WINTHROP PHARMACEUTICALS DE MEXICO SA DE...		-		100%		-		-		-
	SANOFI AVENTIS PHARMA SLOVAKIA SRO		-		100%		-		-		-
	SANOFI-AVENTIS DEL PÉRU SA		-		100%		-		-		-
	SANOFI PASTEUR		-		100%		-		-		-
	SANOFI AVENTIS SPA		-		100%		-		-		-
	SANOFI AVENTIS AUSTRALIA PTY LIMITED		-		100%		-		-		-
	SANOFI SYNTHÉLABO (MALAYSIA) SDN-BHD		-		100%		-		-		-
	AVENTIS PHARMA LTD		-		100%		-		-		-
	SANOFI PHARMA DE MEXICO SA DE CV		-		100%		-		-		-
	SANOFI WINTHROP INDUSTRIE		775662257		100%		100		2 000 000 €		31/12/2010
	PT AVENTIS PHARMA		-		75%		-		-		-
	SPI		388821043		100%		100		250 000 €		31/12/2010
	SANOFI-SYNTHÉLABO VIETNAM PHARMACEUTICAL...		-		70%		-		-		-
	SANOFI-AVENTIS SRO		-		100%		-		-		-
	SANOFI AVENTIS OY		-		100%		-		-		-
	SANOFI-AVENTIS ARGENTINA SA		-		100%		-		-		-
	SANOFI-AVENTIS BELGIUM NV		464435901		100%		95		10 800 000 €		31/12/2010
	SANOFI-AVENTIS RECHERCHE DEVELOPPE...		713002269		95.46%		100		2 000 000 €		31/12/2010

SANOFI AVENTIS NETHERLAND BV		-		100%		-		-		-
	SANOFI-SYNTHELABO UK LIMITED		00692858		100%		69		2 500 000 £		31/12/2010
	SANOFI AVENTIS SINGAPORE PTE LTD		-		100%		-		-		-
	SYNTHELABO TANABE CHIMIE		340723022		50%		100		270 000 €		31/12/2010
	SANOFI AVENTIS KK		-		100%		-		-		-
	SANOFI SYNTHÉLABO MAROC		-		99.99%		-		-		-
	SANOFI AVENTIS SA		-		100%		-		-		-
	SANOFI AVENTIS DENMARK A/S		-		100%		-		-		-
	SANOFI AVENTIS GULF FZE		-		100%		-		-		-
	SANOFI CHIMIE		428706204		100%		89		2 000 000 €		31/12/2010
	FRANCOPIA		775662463		100%		72		2 000 000 €		31/12/2010
	ALCALIBER SA		-		40%		-		-		-
	SANOFI-AVENTIS AEBE GREECE		-		100%		-		-		-
	SANOFI-SYNTHÉLABO (THAILAND) LTD		-		100%		-		-		-
	PT SANOFI AVENTIS INDONESIA		-		100%		-		-		-
	SANOFI AVENTIS AFC (CAMEROUN)		-		100%		-		-		-
	SANOFI AVENTIS (SUISSE) SA		-		100%		-		-		-
	SANOFI-AVENTIS VIETNAM CO. LTD		-		100%		-		-		-
	SANOFI-SYNTHÉLABO SLOVAKIA S.R.O.		-		100%		-		-		-
	PMC 2		414896696		100%		96		550 €		31/12/2010
	SANOFI SYNTHÉLABO ROW BV		-		100%		-		-		-
	SANOFI-AVENTIS US INC		-		100%		-		-		-
	SANOFI SYNTHÉLABO PHILIPPINES INC		-		100%		-		-		-
	SANOFI-AVENTIS THAILAND LTD		-		100%		-		-		-
	SANOFI SYNTHÉLABO POLHOLDING BV		-		100%		-		-		-
	BRISTOL-MYERS SQUIBB / SANOFI-SYNTHÉLABO...		-		49.90%		-		-		-
	AVENTIS PHARMA		1439359		60.40%		10		0 €		31/12/2011
	SANOFI WINTHROP AKTIEBOLAG		-		100%		-		-		-
	SANOFI BIOCOM PHARMA HOLDING		-		50%		-		-		-
	AVENTISUB INC		-		100%		-		-		-
	SANOFI WINTHROP BMS AEIE		-		50.10%		-		-		-
	SANOFI AVENTIS SP ZOO		-		100%		-		-		-
	SANOFI PASTEUR HOLDING		393337597		100%		100		250 000 €		31/12/2010
	SHANTHA BIOTECHNICS		-		96.40%		-		-		-
	SANOFI PASTEUR		349505370		100%		100		2 000 000 €		31/12/2010
	VAXSERVE INC		-		100%		-		-		-
	SANOFI PASTEUR INC (PHILIPPINES)		-		99.90%		-		-		-
	SANOFI PASTEUR GMBH (AUTRICHE)		-		100%		-		-		-
	SANOFI PASTEUR SPOLKA Z.O.O.		-		100%		-		-		-
	SANOFI PASTEUR MSD SNC		392032934		50%		99		2 000 000 €		31/12/2010
	SANOFI PASTEUR ASI TICARET AS		-		99.99%		-		-		-
	SANOFI PASTEUR INC		-		100%		-		-		-
	SHENZHEN SANOFI PASTEUR BIOLOGICAL PRODU...		-		100%		-		-		-
	SANOFI PASTEUR K.K.		-		100%		-		-		-
	AVENTIS PASTEUR SA (ARGENTINE)		-		99.90%		-		-		-
	SANOFI PASTEUR SA (CHILI)		-		99.90%		-		-		-
	SANOFI PASTEUR (THAILAND) LTD		-		99.90%		-		-		-
	SANOFI PASTEUR (COLOMBIE)		-		70%		-		-		-
	SANOFI PASTEUR PTY LTD		-		100%		-		-		-
	SANOFI PASTEUR LTDA (BRÉSIL)		-		99.90%		-		-		-

SANOFI PASTEUR INDIA LTD			99.90%	-		-		-
	SANOFI PASTEUR LTD (CORÉE)	-			100%		-		-	-
	SANOFI PASTEUR HOLDING LIMITED	02863682			100%		54		225 000 £	31/12/2010
	HELVEPHARM	-			Majoritaire		-		-	-
	VAXDESIGN CORPORATION	-			100%		-		-	-
	WINTHROP PHARMACEUTICAL JAPAN CO LTD	-			100%		-		-	-
	SANOFI-AVENTIS FIPART	592054589			100%		100		250 000 €	31/12/2010
	SANOFI DEVELOPPEMENT	308307883			100%		100		25 000 €	31/12/2010
	SANOFI SERVICIOS CORPORATIVOS SA DE CV	-			99.98%		-		-	-
	SANOFI AVENTIS KOREA CO LTD	-			91%		-		-	-
	ARMOUR PHARMACEUTICAL COMPANY	-			100%		-		-	-
	SANOFI AVENTIS AMERIQUE DU NORD	333534949			100%		100		250 000 €	31/12/2010
	SANOFI SYNTHÉLABO INC	-			100%		-		-	-
	SOC FINANCIERE YVES ROCHER	877180513			39.10%		82		250 000 €	31/12/2009
	LABO BIO VEGET Y ROCHER	876580077			49.89%		94		250 000 €	31/12/2009
	GEST DROIT PROPRIET INDU CHOAY	328223813			46%		95		-	31/12/2006
	SANOFI SYNTHÉLABO AFRIQUE SARL	-			100%		-		-	-
	SECIPE	722019965			100%		100		500 €	31/12/2010
	AFRICASOINS	379042872			99.76%		100		270 000 €	31/12/2010
	LABORATOIRES MAPHAR	-			80.60%		-		-	-
	AVENTIS HOLDINGS INC	-			100%		-		-	-
	SANOFI AVENTIS COMERCIAL E LOGISTICA LTD...	-			100%		-		-	-
	FISONS LIMITED	00044687			100%		98		455 000 £	31/12/2010
	SANOFI SYNTHÉLABO DAIICHI PHARMACEUTICAL...	-			51%		-		-	-
	SANOFI SYNTHÉLABO DO BRASIL LTDA	-			100%		-		-	-
	SANOFI GESTION SA	-			97%		-		-	-
	SANOFI BRISTOL MYERS SQUIBB AFRIQUE DU S...	-			51%		-		-	-
	SANOFI-AVENTIS BETEILIGUNGSVERWALTUN...	HRB 81403			100%		No Rating		-	31/12/2009
	SANOFI-SYNTHÉLABO AUSTRALIA PTY LTD	-			100%		-		-	-
	SANOFI-AVENTIS ILACLARI LIMITED SIRKETI	-			100%		-		-	-
	GENZYME	1048023			100%		No Rating		-	31/12/2010
	GENZYME LUXEMBOURG S.ÀR.L.	B97613			100%		No Rating		-	-
	GENZYME GLOBAL S.À R.L.	B66390			100%		No Rating		-	-
	IMTIX SANGSTAT (SWITZERLAND) GMBH	-			100%		-		-	-
	GENZYME EUROPE B.V	-			100%		-		-	-
	GENZYME	399179639			100%		100		2 000 000 €	31/12/2010
	GENZYME POLYCLONALS SAS	418661039			99.90%		100		250 000 €	31/12/2009
	AVENTIS PHARMA ZAO	-			100%		-		-	-
	CARRAIG INSURANCE LTD	-			100%		-		-	-
	MAY AND BAKER LIMITED	-			100%		-		-	-
	BRISTOL MYERS SQUIBB/ SANOFI PHARMACEUTI...	-			49.90%		-		-	-
	WINTHROP FARMACEUTICA PORTUGAL LDA	-			100%		-		-	-
	SANOFI-AVENTIS MALAYSIA SDN BHD	-			100%		-		-	-
	SANOFI 1	487741795			100%		100		1 300 €	31/12/2010
	SANOFI WINTHROP BMS PARTNERSHIP (JV DK)	-			50.10%		-		-	-
	SANOFI AVENTIS PRIVATE CO. LTD	-			99.60%		-		-	-
	MEDLEY COMERCIAL E LOGISTICA LTDA	-			100%		-		-	-
	SANOFI WINTHROP BMS PARTNERSHIP ANS	-			50.10%		-		-	-
	SANOFI-SYNTHELABO LIMITED	02536338			100%		98		550 000 £	31/12/2010

SANOFI SYNTHÉLABO CIS & EASTERN COUNTRIE...			100%	-		-		-
	AVENTIS PHARMACEUTICALS INC	-			100%		-		-	-
	WINTHROP PHARMACEUTICALS PTY LTD	-			100%		-		-	-
	PHARMACHOICE	-			100%		-		-	-
	SANOFI AVENTIS ALGÉRIE	-			100%		-		-	-
	SANOFI AVENTIS PHARMA INC	-			100%		-		-	-
	SANOFI-AVENTIS PHARMA BEIJING CO. LTD	-			100%		-		-	-
	SANOFI AVENTIS MEIJI PHARMACEUTICALS CO ...	-			51%		-		-	-
	WINTHROP PHARMACEUTICALS (MALAYSIA) SDN....	-			100%		-		-	-
	SANOFI AVENTIS WINTHROP SA DE CV	-			100%		-		-	-
	SANOFI-AVENTIS PAKISTAN	2557589			53%		No Rating		-	31/12/2010
	WINTHROP PHARMA TUNISIE	-			100%		-		-	-
	BRISTOL MYERS SQUIBB / SANOFI CANADA PAR...	-			49.90%		-		-	-
	BRISTOL MYERS SQUIBB/ SANOFI PHARMACEUTI...	-			49.90%		-		-	-
	BRISTOL MYERS SQUIBB/ SANOFI PHARMACEUTI...	-			49.90%		-		-	-
	FOVEA PHARMACEUTICALS	482218203			100%		19		0 €	31/12/2010
	SANOFI PASTEUR PARTICIPATIONS	414896613			100%		99		250 000 €	31/12/2010
	SANOFI-AVENTIS UKRAINE LLC	-			100%		-		-	-
	SANOFI PASTEUR BIOLOGICS CO	-			100%		-		-	-
	SANOFI-AVENTIS HEALTHCARE HOLDINGS PTY L...	-			100%		-		-	-
	MCP OPERATIONS PTY LTD	-			100%		-		-	-
	BULLIVANT'S NATURAL HEALTH PRODUCTS (INT...	-			100%		-		-	-
	BULLIVANT'S NATURAL HEALTH PRODUCTS PTY ...	-			100%		-		-	-
	MCP DIRECT PTY LTD	-			100%		-		-	-
	CARLSON HEALTH PTY LTD	-			100%		-		-	-
	SANOFI-AVENTIS HEALTHCARE PTY LTD	-			100%		-		-	-
	CENOVIS PTY LTD	-			100%		-		-	-
	MEDLEY SA	-			100%		-		-	-
	BIPAR SCIENCES INC	-			100%		-		-	-
	BIOTON WOSTOK	-			Majoritaire		-		-	-
	CHATTEM	1146431			100%		No Rating		-	30/11/2009
	CHATTEM GLOBAL CONSUMER PRODUCTS LIMITED	-			100%		-		-	-
	CHATTEM (U.K.) LIMITED	-			100%		-		-	-
	CHATTEM (CANADA) HOLDINGS INC	-			100%		-		-	-
	CHATTEM (CANADA) CORP.	-			100%		-		-	-
	CHATTEM CANADA ULC	-			100%		-		-	-
	CHATTEM CANADA	-			100%		-		-	-
	CHATTEM PERU S.R.L.	-			100%		-		-	-
	NEPENTES	10128525			100%		No Rating		-	31/12/2009
	CANDERM PHARMA INC	-			Majoritaire		-		-	-
	TARGEGEN INC	-			100%		-		-	-
	BMP SUNSTONE CORPORATION	-			100%		-		-	-
	ZENTIVA INHALATIONSPRODUKTE GMBH	-			100%		-		-	-
	CHATTEM GREECE S.A.	-			100%		-		-	-
	ZENTIVA GROUP A.S	-			100%		-		-	-
	SANOFI-AVENTIS VOSTOK	-			51%		-		-	-
	HBA INDEMNITY INSURANCE LTD	-			100%		-		-	-

SIGNAL INVESTMENT & MANAGEMENT CO

100%

SUNDEX LLC

100%

SANOFI PHARMA GENERAL PARTNERSHIP

100%

HANGZHOU SANOFI MINSHENG CONSUMER HEALTH...

60%

SANOFI-AVENTIS LATIN AMERICA SA

100%

SANOFI PASTEUR MERIEUX

492623996

Majoritaire

7 600 €

31/12/2010

AVENTIS (IRELAND) LTD

100%

WARP DRIVE BIO

Min de blocage

Linkages

Ultimate parent company	SANOFI
Direct parent	SANOFI-AVENTIS PARTICIPATIONS SAS - 100 %
Group – Number of companies	295
Linkages – Number of companies	174
Number of countries	28

	SIREN	Dernier bilan	Score	Limite	CA
MITSUBISHI CHEMICAL	2553578	31/03/2011	90	50 000 000 €	27 154 846 123 €
MITSUBISHI TANABE PHARMA	2069	31/03/2011	80	50 000 000 €	3 511 777 669 €
SCHERING-PLOUGH	107821	31/12/2011	48	50 000 000 €	33 345 131 515 €
KAWASAKI KASEI CHEMICALS	687587	31/03/2011	42	1 200 000 €	134 394 910 €
NIPPON KASEI CHEMICAL	2495	31/03/2011	44	935 000 €	335 434 192 €
NITTO KAKO	2049529	31/03/2011	38	200 000 €	83 343 795 €
KODAMA CHEMICAL INDUSTRY	742387	31/03/2011	36	215 000 €	152 243 588 €
MERCK SHARP & DOHME (HOLDINGS) LIMITED	00233687	31/12/2010	95	7 100 000 £	0 £
MERCK SHARP & DOHME FINANCE EUROPE LIMIT...	02866198	31/12/2010	96	15 000 000 £	15 258 999 £
SANOFI-AVENTIS FINANCE (IRELAND)	IE262408	31/12/2010	74	15 000 000 €	4 677 186 €
MBL (1991) LIMITED	00033021	31/12/1990	No Rating	-	94 783 000 £
MERCK SHARP & DOHME LIMITED	00820771	31/12/2010	98	10 750 000 £	559 258 000 £
MERIAL LIMITED	03332751	31/12/2010	92	11 450 000 £	1 480 776 317 £
SANOFI-AVENTIS HOLDINGS (IRELAND) LIMITE...	IE168162	31/12/2010	65	50 000 €	0 €
AVENTIS PHARMA HOLDINGS LIMITED	03835646	31/12/2010	50	25 000 £	0 £
HOECHST TREVIRA GMBH & CO KG	HRA 27571	31/12/2010	42	26 500 €	-
HOECHST MARION ROUSSEL LIMITED	02945218	31/12/2010	49	290 000 £	0 £
ORGANON LABORATORIES LIMITED	00353334	31/12/2010	98	1 050 000 £	129 436 000 £
INTERVET UK LIMITED	00946942	31/12/2010	98	850 000 £	106 259 000 £
AVENTIS BETEILIGUNGSVERWALTUNG GMBH	HRB 55472	31/12/2009	42	5 900 000 €	-
DASHTAG	00090627	31/12/2010	92	520 000 £	0 £
A. NATTERMANN & CIE. GESELLSCHAFT MIT BE...	HRB 1493	31/12/2010	71	880 000 €	147 856 799 €
SCHERING-PLOUGH LIMITED	00020626	31/12/2010	98	3 700 000 £	449 541 000 £
AVENTIS PHARMA LIMITED	01535640	31/12/2010	96	4 300 000 £	478 790 000 £
GENZYME INTERNATIONAL HOLDINGS LIMITED	IE409980	31/12/2010	95	100 000 €	0 €
SANOFI-AVENTIS DEUTSCHLAND GMBH	HRB 40661	31/12/2009	62	15 000 000 €	5 182 053 000 €
ROUSSEL LABORATORIES LIMITED	00336062	31/12/2010	57	2 350 000 £	0 £
MITSUBISHI PHARMA EUROPE LTD	04134678	31/12/2010	98	650 000 £	22 867 283 £
INTERVET UK PRODUCTION LIMITED	03200055	31/12/2010	98	310 000 £	37 870 000 £
EUROPEAN INSURANCE RISK EXCESS LIMITED	IE358389	31/12/2010	90	1 400 000 €	530 313 €
INTERVET (IRELAND) LIMITED	IE031789	31/12/2009	No Rating	-	27 135 040 €
GENZYME IRELAND LIMITED	IE316537	31/12/2010	98	8 050 000 €	980 444 000 €
SANOFI-AVENTIS UK HOLDINGS LIMITED	03203829	31/12/2010	83	100 000 £	0 £
GENZYME GMBH	HRB 12497	31/12/2011	77	1 000 000 €	156 513 405 €
ACAMBIS RESEARCH LIMITED	02774777	31/12/2010	93	57 000 £	7 302 000 £
AVENTIS REAL ESTATE GMBH	HRB 76004	31/12/2010	59	50 000 €	-
SCHERING-PLOUGH (IRELAND) COMPANY	IE113077	31/12/2002	No Rating	-	0 €
MITSUBISHI CHEMICAL EUROPE GMBH	HRB 24804	31/12/2010	85	970 000 €	135 812 039 €
SANOFI PASTEUR MSD GMBH	HRB 333558	31/12/2010	46	30 000 €	167 466 520 €
ZENTIVA N.V.	33302572	31/12/2010	68	86 000 €	-
SCHERING-PLOUGH HOLDINGS LIMITED	02297208	31/12/2010	95	1 750 000 £	0 £
SANOFI PASTEUR MSD LIMITED	01227497	31/12/2011	98	1 000 000 £	120 717 513 £
MAY & BAKER LIMITED	02450361	31/12/2010	98	11 100 000 £	1 347 709 000 £
GENZYME LIMITED	01556886	31/12/2010	97	1 650 000 £	201 541 000 £
RHONE-POULENC RORER LIMITED	01989256	31/12/2010	68	3 500 000 £	0 £

MERCK SHARP & DOHME IRELAND (HUMAN HEALT...	IE376424	31/12/2010	98	180 000 €	21 992 683 €
SCHERING-PLOUGH PHARMACEUTICALS (IRELAND...	IE407504	31/12/2010	96	100 000 €	10 813 748 €
GENZYME EUROPE B.V.	32050737	31/12/2010	58	12 850 000 €	743 272 000 €
MERCK SHARP & DOHME (HOLDINGS) B.V.	34217449	31/12/2009	No Rating	-	-
DIOGENES ACHTE VERMÖGENSVERWALTUNGS GMBH	HRB 43555	31/12/2010	53	2 500 €	0 €
ALBERT-ROUSSEL PHARMA GMBH	HRB 23118	31/12/2010	No Rating	-	-
DELALANDE ARZNEIMITTEL GMBH	HRB 65680 B	31/12/2010	40	2 500 €	-
HENNING BERLIN ARZNEIMITTEL GMBH	HRB 66343 B	31/12/2010	50	2 500 €	-
MIDY GMBH PHARMAZEUTISCHE PRÄPARATE	HRB 90303 B	31/12/2010	39	2 500 €	-
AVENTIS PHARMA DEUTSCHLAND GMBH	HRB 48559	31/12/2010	45	2 500 €	-
ZENTIVA PHARMA GMBH	HRB 81795	31/12/2009	48	2 500 €	-
ZENTIVA INHALATIONSPRODUKTE GMBH	HRB 166853	31/12/2009	59	45 500 €	-
MITSUBISHI PHARMA DEUTSCHLAND GMBH	HRB 47940	31/12/2010	68	185 000 €	-
CHATTEM (U.K.) LIMITED	01472031	31/12/2010	78	195 000 £	1 597 204 £
SANOFI-AVENTIS INVESTMENTS B.V.	24473571	31/12/2010	23	0 €	-
DIOSYNTH HOLDING B.V.	09091868	31/12/2010	88	5 000 €	-
SANOFI PASTEUR MSD LIMITED	IE141204	31/12/2010	93	200 000 €	8 645 832 €
RPR (US) LIMITED	03203835	31/12/2010	58	7 650 000 £	0 £
FISONS INTERNATIONAL HOLDINGS LIMITED	00497696	31/12/1995	No Rating	-	0 £
ANCARE IRELAND LIMITED	IE187594	31/12/2010	51	1 000 €	-
GENZYME PENSION TRUSTEES LIMITED	01595921	31/12/2010	No Rating	-	0 £
SANOFI-AVENTIS IRELAND LIMITED	IE166500	31/12/2010	93	490 000 €	62 981 126 €
CONTINUUM PROFESSIONAL SERVICES LIMITED	04320190	30/11/2010	94	100 000 £	-
SANOFI-AVENTIS PENSIONS TRUST LIMITED	03545604	31/12/2010	No Rating	-	0 £
CHATTEM GLOBAL CONSUMER PRODUCTS LIMITED	IE378132	31/12/2010	94	255 000 €	6 329 502 €
S-P VETERINARY (UK) LIMITED	00427991	31/12/2010	No Rating	-	-
PLOUGH (U.K.) LIMITED	00438470	31/12/2010	No Rating	-	-
MSD CONSUMER CARE LIMITED	00459661	31/12/2010	No Rating	-	-
S-P RIL LIMITED	00698405	31/12/2010	No Rating	-	-
COOPERS ANIMAL HEALTH LIMITED	00711852	31/12/2010	No Rating	-	-
MYCOFARM UK LIMITED	00909517	31/12/2010	No Rating	-	-
SCHERING-PLOUGH INT LIMITED	00934125	31/12/2010	No Rating	-	-
CHARLES E.FROSST(U.K.)LIMITED	00955192	31/12/2010	No Rating	-	-
TASMAN VACCINE LABORATORY(U.K.)LIMITED	00963983	31/12/2010	No Rating	-	-
DIOSYNTH LIMITED	01036095	31/12/2010	No Rating	-	-
NOURYPHARMA LIMITED	01231773	31/12/2010	No Rating	-	-
KIRBY-WARRICK PHARMACEUTICALS LIMITED	01287555	31/12/2010	No Rating	-	-
THOMAS MORSON & SON LIMITED	01535776	31/12/2010	No Rating	-	-
LOREX SYNTHELABO LIMITED	01572023	31/12/2010	No Rating	-	-
RORER HEALTH CARE LIMITED	01615960	31/12/2010	No Rating	-	-
AQUACULTURE VACCINES LIMITED	01683685	31/12/2010	No Rating	-	-
S-P VETERINARY LIMITED	01782521	31/12/2010	No Rating	-	-
ARK PRODUCTS LIMITED	01848770	31/12/2010	No Rating	-	-
S-P VETERINARY PENSIONS LIMITED	01908729	31/12/2010	No Rating	-	-
AQUACULTURE HOLDINGS LIMITED	01909980	31/12/2010	No Rating	-	-
RORER PHARMACEUTICALS LIMITED	01998670	31/12/2010	No Rating	-	-
S-P VETERINARY HOLDINGS LIMITED	02197451	31/12/2010	No Rating	-	-
SP/OBS (UK) PENSION TRUSTEE LTD.	02514484	31/12/2010	No Rating	-	-
VETREX LIMITED	02618414	31/12/2010	No Rating	-	-
THE MSD FOUNDATION LIMITED	02744400	31/12/2010	No Rating	-	-
GENZYME VEHICLE LEASING LIMITED	03064054	31/12/2010	No Rating	-	-
AVL HOLDINGS LIMITED	03294874	31/12/2010	No Rating	-	-
BIOENVISION LIMITED	03714084	31/12/2010	No Rating	-	-
GENZYME THERAPEUTICS LIMITED	04316333	31/12/2010	94	700 000 £	87 395 000 £
MSD LIMITED	05142753	31/12/2010	No Rating	-	-
ROSETTA BIOSOFTWARE UK LIMITED	05997529	31/12/2010	No Rating	-	-
SANOFI WINTHROP BRISTOL-MYERS	980556530	31/12/2010	54	510 €	4 170 652 €

AVENTIS PHARMA (WATERFORD) LIMITED	IE025380	31/12/2009	No Rating	-	-
CHEMIBIOTIC (IRELAND) LIMITED	IE038255	31/12/2010	No Rating	-	-
SCHERING-PLOUGH ANIMAL HEALTH LIMITED	IE122770	31/12/2010	No Rating	-	-
LITTLE SYCAMORE LIMITED	IE276466	31/12/2010	83	100 000 €	1 570 000 €
AVENTIS (IRELAND) LIMITED	IE316908	31/12/2009	No Rating	-	-
SCHERING-PLOUGH (BRAY)	IE376828	31/12/2010	No Rating	-	-
CHIRON	1053023	-	No Rating	-	-
GENZYME A/S	18296380	-	43	2 000 €	-
BIOENVISION	2161177	-	No Rating	-	-
MITSUBISHI PLASTICS	2323	-	No Rating	-	-
MITSUBISHI CHEMICAL	2334	-	No Rating	-	-
IGI INSURANCE	2568658	-	No Rating	-	-
TANABE SEIYAKU (MALAYSIA)	2569217	-	No Rating	-	-
TANABE EUROPE NV	412863276	31/12/2010	78	290 000 €	18 835 859 €
PHARMING NV	458398640	31/12/2003	No Rating	-	-
GENZYME FLANDERS BVBA	475955046	31/12/2010	100	4 650 000 €	200 145 656 €
AVENTIS REAL ESTATE MANAGEMENT GMBH	HRB 45214	-	No Rating	-	-
RHÔNE-POULENC PHARMA GMBH	HRB 12633	-	No Rating	-	-
HISTOCOM GMBH	HRB 46954	-	No Rating	-	-
AVENTIS REAL ESTATE GMBH & CO.KG	HRA 28214	-	No Rating	-	-
HOECHST AKTIENGESELLSCHAFT	HRB 14500	-	No Rating	-	-
SCHERING-PLOUGH HOLDINGS (IRELAND) COMPA...	IE376827	-	No Rating	-	-
CARRAIG FINANCE LIMITED	IE388362	-	No Rating	-	-
ORGANON BIOSCIENCES REINSURANCE LIMITED	IE429428	31/12/2010	No Rating	-	-
SCHERING-PLOUGH LIMITED	IE902222	-	No Rating	-	-
AVENTIS BULK S.P.A.	-	-	No Rating	-	-
AVENTIS HOLDINGS INC	-	-	No Rating	-	-
AVENTIS INC	-	-	No Rating	-	-
AVENTIS INC	-	-	No Rating	-	-
AVENTIS INTERCONTINENTAL	-	-	No Rating	-	-
AVENTIS LIMITED	-	-	No Rating	-	-
AVENTIS PHARMA (PTY) LTD	-	-	No Rating	-	-
AVENTIS PHARMA EXPORTS LIMITED	-	-	No Rating	-	-
AVENTIS PHARMA INVESTMENT LIMI	-	-	No Rating	-	-
AVENTIS PHARMA LIMITED	-	-	No Rating	-	-
AVENTIS PHARMA LIMITED	-	-	No Rating	-	-
AVENTIS PHARMA LIMITED	-	-	No Rating	-	-
AVENTIS PHARMA PTE LTD	-	-	No Rating	-	-
AVENTIS PHARMA PTY LTD	-	-	No Rating	-	-
AVENTIS PHARMA S.P.A.	-	-	No Rating	-	-
AVENTIS PHARMA SA	-	-	No Rating	-	-
AVENTIS PHARMA SENEGAL	-	-	No Rating	-	-
AVENTIS PHARMACEUTICALS INC	-	-	No Rating	-	-
AVENTIS SA	-	-	No Rating	-	-
BIOMARIN/GENZYME LLC	-	-	No Rating	-	-
CHATTEM (CANADA) HOLDINGS,, IN	-	-	No Rating	-	-
CHATTEM (U.K) LIMITED	-	-	No Rating	-	-
CHATTEM GLOBAL CONSUMER	-	-	No Rating	-	-
CHATTEM(CANADA)CORP	-	-	No Rating	-	-
CHATTER CANADA	-	-	No Rating	-	-
CHATTER CANADA ULC	-	-	No Rating	-	-
CHIRON BEHRING GMBH & CO	-	-	No Rating	-	-
CHIRON BEHRING VACCINES	-	-	No Rating	-	-
CHIRON S.P.A.	-	-	No Rating	-	-
FISON-HOLMES CHAPEL LTD	-	-	No Rating	-	-
GENZYME A/S	-	-	No Rating	-	-
GENZYME PHARMACEUTICALS	-	-	No Rating	-	-
GENZYME POLYCLONALS S.A.S.	-	-	No Rating	-	-
GENZYME SECURITIES CORPORATION	-	-	No Rating	-	-
GLBC LLC	-	-	No Rating	-	-
GRUPPO LEPETIT S.P.A.	-	-	No Rating	-	-
HBA INDEMNITY INSURANCE, LTD.	-	-	No Rating	-	-
HOECHST MARION ROUSSEL LIMITED	-	-	No Rating	-	-
M/S ALI GOHAR & CO. (PVT) LTD.	-	-	No Rating	-	-
MERIAL SAS	-	-	No Rating	-	-
PT AVENTIS PHARMA INDONESIA	-	-	No Rating	-	-
SANGSTAT ATLANTIQUE	-	-	No Rating	-	-
SANOFI AVENTIS SA	-	-	No Rating	-	-
SANOFI-AVENTIS PARTICIPATION SA	-	-	No Rating	-	-
SECIPE OF PARIS, FRANCE	-	-	No Rating	-	-
SIGNAL INVESTMENT & MANAGEMENT	-	-	No Rating	-	-
SUNDEX, LLC	-	-	No Rating	-	-

FINANCIAL INFORMATION

accounts

Active Account | Passive Account | Account Results

Synthesized Accounts

Display parameter
Currency	Euro	Kilo Euro
Comparison mode	Average	Median

Annual Accounts	31/12/2010	31/12/2009	31/12/2008
Account period (month)	12	12	12
Account Type	Normal	Normal	Normal
Deposit date	15/06/2011	22/07/2010	-
Activity Code	2110Z	2110Z	2110Z
Employees	4202	4255	4259

Active account

Annual Accounts	31/12/2010		31/12/2009		31/12/2008	Sector Median 2010
Capital not called	0	0%	0	0%	0	0	0%
Total fixed assets	788 039 000	2,8%	766 349 000	1,1%	758 105 000	441 529	178379,6%
- Intangible assets	5 497 000	16,3%	4 726 000	-28,4%	6 599 000	5 391	101866,2%
- Tangible assets	765 078 000	2,9%	743 579 000	1,3%	734 267 000	193 058	396194,4%
- Financial assets	17 464 000	-3,2%	18 044 000	4,7%	17 240 000	4 230	412760,5%
Net current assets	1 129 293 000	7,5%	1 050 684 000	38,6%	758 169 000	1 528 847	73765,7%
- Stocks	667 319 000	21,8%	547 977 000	14,2%	480 043 000	137 970	483569,6%
- Advanced payments	14 273 000	7,5%	17 879 000	471,0%	3 131 000	0	0%
- Receivables	447 637 000	-7,6%	484 291 000	77,2%	273 240 000	713 013	62681,0%
- Securities and cash	64 000	-88,1%	537 000	-69,4%	1 755 000	109 903	-41,8%
- Prepaid expenses	-	-	-	-	-	2 917	-
Accounts of regularization	740 000	40,7%	526 000	182,8%	186 000	0	0%
Total Assets	1 918 072 000	5,5%	1 817 560 000	19,9%	1 516 461 000	1 980 045	96770,1%

Passive Account

Annual Accounts	31/12/2010		31/12/2009		31/12/2008	Sector Median 2010
Shareholders' equity	661 621 000	-33,9%	1 001 670 000	6,0%	944 744 000	718 442	91991,1%
Share capital	524 786 000	0%	524 786 000	0%	524 786 000	350 000	149838,9%
Other capital resources	0	0%	0	0%	0	0	0%
Risk Provisions	574 402 000	97,5%	290 790 000	1,9%	285 500 000	0	0%
Liabilities	681 743 000	29,8%	525 050 000	84,5%	284 632 000	912 990	74571,5%
- Financial liabilities	332 408 000	53,8%	216 075 000	709,6%	26 688 000	268 268	123808,9%
- Advanced payments received	0	0%	0	0%	0	0	0%
- Trade account payables	181 436 000	13,6%	159 645 000	23,2%	129 535 000	269 424	67242,2%
- Tax and social liabilities	114 563 000	-7,2%	123 476 000	14,8%	107 582 000	172 718	66229,5%
- Other debts and fixed assets liabilities	53 642 000	107,1%	25 905 000	15,6%	22 410 000	8 291	646890,7%
Account regularization	0	0%	0	0%	0	0	0%
Total liabilities	1 918 072 000	5,5%	1 817 560 000	19,9%	1 516 461 000	1 980 045	96770,1%

Results

Annual Accounts	31/12/2010		31/12/2009		31/12/2008	Sector Median 2010
Sales of Goods	1 838 178 000	27,9%	1 437 584 000	26,1%	1 140 407 000	2 017 020	91033,4%
Net turnover	1 620 853 000	24,9%	1 297 263 000	25,8%	1 031 367 000	2 016 615	80274,9%
- of which net export turnover	686 841 000	71,8%	399 711 000	407,9%	78 699 000	116 175	591112,4%
Operating charges	1 895 953 000	35,7%	1 397 206 000	19,8%	1 166 265 000	1 943 777	97439,6%
Operating profit/loss	-57 775 000	-243,1%	40 378 000	256,2%	-25 858 000	37 991	-152175,5%
Financial income	9 251 000	79,8%	5 144 000	-15,1%	6 059 000	811	1140590,5%
Financial charges	15 198 000	40,5%	10 817 000	38,7%	7 800 000	13 714	110721,1%
Financial profit/loss	-5 947 000	-4,8%	-5 672 000	-226,0%	-1 740 000	-522	-1139172,0%
Pretax net operating income	-57 394 000	-248,0%	38 768 000	235,3%	-28 659 000	37 991	-151172,6%
Extraordinary income	24 464 000	-59,1%	59 760 000	27,8%	46 756 000	3 680	664682,6%
Extraordinary charges	208 978 000	499,6%	34 850 000	-21,2%	44 236 000	11 055	1890248,3%
Extraordinary profit/loss	-184 514 000	-1131,8%	24 910 000	888,5%	2 520 000	-14	-1317957042,9%
Net result	-257 016 000	-565,8%	55 180 000	267,8%	-32 893 000	57 557	-446641,7%

Display parameter
Currency	Euro	Kilo Euro

	Normal Account		31/12/2010		31/12/2009		31/12/2008
	Months		12		12		12

Accounts - Active
Current Assets | Equalization accounts | Reference

Grand Total - Passive Accounts (I to IV)

		31/12/2010		31/12/2009		31/12/2008
Grand Total (I to VI)	Net	1 918 072 000	5,5%	1 817 560 000	19,9%	1 516 461 000
Gross	CO	3 563 415 000	6,5%	3 345 941 000	7,9%	3 101 493 000
Amortisation	1A	1 645 343 000	7,7%	1 528 382 000	-3,6%	1 585 032 000

Non declared distributed capital (I)

		31/12/2010		31/12/2009		31/12/2008
Non declared distributed capital (I)	AA3	0	0%	0	0%	0
Gross	AA	0	0%	0	-	0

Active fixed asset (II)

		31/12/2010		31/12/2009		31/12/2008
Total Active fixed asset (II)	Net	788 039 000	2,8%	766 349 000	1,1%	758 105 000
Gross	BJ	2 433 382 000	6,0%	2 294 731 000	4,1%	2 203 699 000
Amortisation	BK	1 645 343 000	7,7%	1 528 382 000	5,7%	1 445 593 000

Intangilble fixed assets

			31/12/2010		31/12/2009		31/12/2008
	Start-up cost	Net	0	0%	0	0%	0
	Gross	AB	0	0%	0	0%	0
	Amortisation	AC	0	0%	0	0%	0
	R & D expenses	Net	0	0%	0	0%	0
	Gross	CX	0	0%	0	0%	0
	Amortisation	AE	0	0%	0	0%	0
	Distributorships, patents	Net	0	0%	0	0%	0
	Gross	AF	0	0%	0	0%	0
	Amortisation	AG	0	0%	0	0%	0
	Goodwill	Net	0	0%	0	0%	0
	Gross	AH	0	0%	0	0%	0
	Amortisation	AI	0	0%	0	0%	0
	Other intangible fixed assets	Net	5 497 000	16,3%	4 726 000	-28,4%	6 599 000
	Gross	AJ	31 705 000	6,5%	29 781 000	-1,3%	30 178 000
	Amortisation	AK	26 208 000	4,6%	25 055 000	6,3%	23 579 000
	Pre-payments and downpayments	Net	0	0%	0	0%	0
	Gross	AL	0	0%	0	0%	0
	Amortisation	AM	0	0%	0	0%	0
Sub Total Intangible Assets		Net	5 497 000	16,3%	4 726 000	-28,4%	6 599 000

Tangilble fixed assets

		31/12/2010		31/12/2009		31/12/2008
Lands	Net	26 285 000	-1,4%	26 646 000	17,2%	22 738 000
Gross	AN	38 227 000	2,6%	37 253 000	15,0%	32 385 000
Amortisation	AO	11 942 000	12,6%	10 607 000	10,0%	9 647 000
Buildings	Net	166 314 000	-5,4%	175 846 000	1,0%	174 105 000
Gross	AP	465 560 000	2,3%	455 182 000	5,5%	431 487 000
Amortisation	AQ	299 246 000	7,1%	279 336 000	8,5%	257 382 000
Plant	Net	0	0%	0	0%	0
Gross	AR	0	0%	0	0%	0
Amortisation	AS	0	0%	0	0%	0
Other tangible fixed assets	Net	363 464 000	-19,7%	452 746 000	-3,5%	469 083 000
Gross	AT	1 671 411 000	2,2%	1 636 223 000	2,6%	1 594 244 000
Amortisation	AU	1 307 947 000	10,5%	1 183 477 000	5,2%	1 125 161 000
Fixed assets in construction	Net	209 015 000	136,6%	88 341 000	29,3%	68 341 000
Gross	AV	209 015 000	76,8%	118 248 000	20,5%	98 159 000
Amortisation	AW	0	0%	29 907 000	0,3%	29 818 000
Advances and payments on account	Net	0	0%	0	0%	0
Gross	AX	0	0%	0	0%	0
Amortisation	AY	0	0%	0	0%	0
Sub Total Tangible asset	Net	765 078 000		743 579 000		734 267 000

Financial assets

		31/12/2010		31/12/2009		31/12/2008
Associates at equity	Net	0	0%	0	0%	0
Gross	CS	0	0%	0	0%	0
Amortisation	CT	0	0%	0	0%	0
Other participations	Net	14 823 000	0%	14 823 000	0%	14 823 000
Gross	CU	14 823 000	0%	14 823 000	0%	14 823 000
Amortisation	CV	0	0%	0	0%	0
Inter-company receivables	Net	0	0%	0	0%	0
Gross	BB	0	0%	0	0%	0
Amortisation	BC	0	0%	0	0%	0
Other investment securities	Net	0	0%	0	0%	0
Gross	BD	0	0%	0	0%	0
Amortisation	BE	0	0%	0	0%	0
Loans	Net	0	0%	0	0%	0
Gross	BF	0	0%	0	0%	0
Amortisation	BG	0		0		0
Other financial assets	Net	2 641 000	-18,0%	3 221 000	33,3%	2 417 000
Gross	BH	2 641 000	-18,0%	3 221 000	32,9%	2 423 000
Amortisation	BI	0	0%	0	0%	6 000
Sub Total Financial Assets		17 464 000		18 044 000		17 240 000

Current Assets (III)

		31/12/2010		31/12/2009		31/12/2008
Total Assets	Net	1 129 293 000	7,5%	1 050 684 000	38,6%	758 169 000
Gross	CJ	1 129 293 000	7,5%	1 050 684 000	17,1%	897 608 000
Amortisation	CK	0	0%	0	0%	139 439 000

Stocks

		31/12/2010		31/12/2009		31/12/2008
Raw materials	Net	0	0%	0	0%	74 997 000
Gross	BL	0	0%	0	0%	125 936 000
Amortisation	BM	0	0%	0	0%	50 939 000
Work in progress (goods)	Net	667 319 000	0%	0	0%	9 174 000
Gross	BN	667 319 000	0%	0	0%	9 174 000
Amortisation	BO	0	0%	0	0%	0
Work in progress (services)	Net	0	0%	0	0%	0
Gross	BP	0	0%	0	0%	0
Amortisation	BQ	0	0%	0	0%	0
Semi-finished and finished products	Net	0	0%	0	0%	395 872 000
Gross	BR	0	0%	0	0%	484 344 000
Amortisation	BS	0	0%	0	0%	88 472 000
Goods for resale	Net	0	0%	547 977 000	0%	0
Gross	BT	0	0%	547 977 000	0%	0
Amortisation	BU	0	0%	0	0%	0
Sub Total Stocks	Net	667 319 000	21,8%	547 977 000	14,2%	480 043 000

Advance payments to suppliers

		31/12/2010		31/12/2009		31/12/2008
Advance payments to suppliers	Net	14 273 000	-20,2%	17 879 000	471,0%	3 131 000
Gross	BV	14 273 000	-20,2%	17 879 000	471,0%	3 131 000
Amortisation	BW	0	0%	0	0%	0

Debtors

		31/12/2010		31/12/2009		31/12/2008
Trade accounts receivable	Net	384 053 000	-10,9%	431 230 000	115,0%	200 569 000
Gross	BX	384 053 000	-10,9%	431 230 000	115,0%	200 580 000
Amortisation	BY	0	0%	0	0%	11 000
Other debtors	Net	61 618 000	19,8%	51 453 000	-27,6%	71 053 000
Gross	BZ	61 618 000	19,8%	51 453 000	-27,6%	71 070 000
Amortisation	CA	0	0%	0	0%	17 000
Capital subscribed and called up	Net	0	0%	0	0%	0
Gross	CB	0	0%	0	0%	0
Amortisation	CC	0	0%	0	0%	0
Sub Total Debtors	Net	445 671 000	-7,7%	482 683 000	77,7%	271 622 000

Divers

31/12/2010

31/12/2009

31/12/2008

Investment securities

Net

Gross

Amortisation

Cash and cash equivalents

Net

64 000

-88,1%

537 000

-69,4%

1 755 000

Gross

64 000

-88,1%

537 000

-69,4%

1 755 000

Amortisation

Sub Total Divers

Net

64 000

-88,1%

537 000

-69,4%

1 755 000

Prepaid expenses

		31/12/2010		31/12/2009		31/12/2008
Prepaid expenses	Net	1 966 000	22,3%	1 608 000	-0,6%	1 618 000
Gross	CH	1 966 000	22,3%	1 608 000	-0,6%	1 618 000
Amortisation	CI	0	0%	0	0%	0

Equalization accounts (IV to VI)

		31/12/2010		31/12/2009		31/12/2008
Multi-period charges	CW3	0	0%	0	0%	0
Gross		0	0%	0	-	-
Premiums on redemption of bonds	CM3	0	0%	0	0%	0
Gross		0	0%	0	-	-
Currency differential gain	CN3	740 000	40,7%	526 000	182,8%	186 000
Gross		740 000	40,7%	526 000	-	-

References

		31/12/2010		31/12/2009		31/12/2008
Due within one year	CP	0	0%	0	0%	0
Due after one year	CR	0	0%	0	0%	0

Display parameter
Currency	Euro	Kilo Euro

			31/12/2010		31/12/2009		31/12/2008
	Grand Total (I to V)	EE	1 918 072 000	5,5%	1 817 560 000	19,9%	1 516 461 000

Shareholder Equity (I)

		31/12/2010		31/12/2009		31/12/2008
Total shareholders' equity (Total I)	DL	661 621 000	-33,9%	1 001 670 000	6,0%	944 744 000
Equity and shareholders' equity	DA	524 786 000	0%	524 786 000	0%	524 786 000
Issue and merger premiums	DB	190 666 000	0%	190 666 000	0%	190 666 000
Revaluation differentials	DC	0	0%	0	0%	0
Of which equity differential	EK	0	0%	0	0%	0
Legal reserve	DD	10 359 000	36,3%	7 600 000	0%	7 600 000
Statutory or contractual reserve	DE	0	0%	0	0%	0
Special regulated reserves	DF	0	0%	0	0%	0
Of which special reserve of provisions for current fluctuation	B1	0	0%	0	0%	0
Other reserves	DG	0	0%	0	0%	0
Of which reserve for buying originals works from alive artists	EJ	0		0	0%	0
Profits or losses brought forward	DH	1 523 000	-95,4%	33 069 000	-49,9%	65 961 000
Profit or loss for the period	DI	-257 016 000	-565,8%	55 180 000	267,8%	-32 893 000
Investment grants	DJ	3 416 000	-8,3%	3 725 000	2,5%	3 635 000
Special tax-allowable reserves	DK	187 887 000	0,7%	186 644 000	0,9%	184 989 000

Other capital resources (II)

		31/12/2010		31/12/2009		31/12/2008
Total other capital resources (Total II)	DO	0	0%	0	0%	0
Income from participating securities	DM	0	0%	0	0%	0
Conditional loans	DN	0	0%	0	0%	0

Provisions for risks and charges (III)

		31/12/2010		31/12/2009		31/12/2008
Total provisions for risks and charges (Total III)	DR	574 402 000	97,5%	290 790 000	1,9%	285 500 000
Risk provisions	DP	308 731 000	127,9%	135 480 000	-3,7%	140 701 000
Reserves for charges	DQ	265 671 000	71,1%	155 310 000	7,3%	144 799 000

Liabilities (IV)

		31/12/2010		31/12/2009		31/12/2008
Total Liabilities (Total IV)	EC	681 743 000	29,8%	525 050 000	84,5%	284 632 000
Convertible debentures	DS	0	0%	0	0%	0
Other debentures	DT	0	0%	0	0%	0
Bank loans and liabilities	DU	461 000	136,4%	195 000	-25,0%	260 000
Sundry loans and financial liabilities	DV	331 947 000	53,8%	215 880 000	716,9%	26 428 000
Of which participating loans	EI	0	0%	0	0%	0
Advance payments received for current orders	DW	0	0%	0	0%	0
Trade accounts payables	DX	181 436 000	13,6%	159 645 000	23,2%	129 535 000
Tax and social security liabilities	DY	114 563 000	-7,2%	123 476 000	14,8%	107 582 000
Fixed asset liabilities	DZ	42 441 000	169,2%	15 766 000	28,8%	12 239 000
Other debts	EA	10 895 000	8,0%	10 088 000	17,5%	8 588 000

Translation loss (V)

			31/12/2010		31/12/2009		31/12/2008
	Translation loss (Total V)	ED	306 000	500%	51 000	-96,8%	1 583 000

Equalization accounts

			31/12/2010		31/12/2009		31/12/2008
	Deferred income	EB	0	0%	0	0%	0

References

		31/12/2010		31/12/2009		31/12/2008
Of which tax-allowable reserve	EF	0	0%	0	0%	0
Deferred income and liabilities	EG	0	0%	0	0%	0
Of which current bank facilities	EH	0	0%	0	0%	0

Display parameter
Currency	Euro	Kilo Euro

1- Operating result (I-II)

			31/12/2010		31/12/2009		31/12/2008
	Operating result (Total I-II)	GG	-57 775 000	-243,1%	40 378 000	256,2%	-25 858 000

2 - Financial result (V - VI)

			31/12/2010		31/12/2009		31/12/2008
	Financial result (Total V-VI)	GV	-5 947 000	-4,8%	-5 672 000	-226,0%	-1 740 000

3 - Pre-tax net operating income result (I - VI)

			31/12/2010		31/12/2009		31/12/2008
	Pre-tax net operating income (Total I-II+II-IV+V-VI)	GW	-57 394 000	-248,0%	38 768 000	235,3%	-28 659 000

4 - Extraordinary result (VII-VIII)

			31/12/2010		31/12/2009		31/12/2008
	Extraordinary result (Total VII-VIII)	HI	-184 514 000	-840,7%	24 910 000	888,5%	2 520 000

Profit or loss

			31/12/2010		31/12/2009		31/12/2008
	Profit or loss	HN	-257 016 000	-565,8%	55 180 000	267,8%	-32 893 000

Total Income (I+III+V+VII)

			31/12/2010		31/12/2009		31/12/2008
	Total Income (I+III+V+VII)	HL	1 878 221 000	24,7%	1 506 551 000	26,4%	1 192 160 000

Total charges (Total II+IV+VI+VIII+IX+X)

			31/12/2010		31/12/2009		31/12/2008
	Total charges (Total II+IV+VI+VIII+IX+X)	HM	2 135 236 000	47,1%	1 451 372 000	18,5%	1 225 053 000

Operating income (I)

			31/12/2010		31/12/2009		31/12/2008
	Total operating income (Total I)	FR	1 838 178 000	27,9%	1 437 584 000	26,1%	1 140 407 000

Operating income (details)

		31/12/2010		31/12/2009		31/12/2008
Sale of goods for resale	FC	3 085 000	1100,4%	257 000	-94,2%	4 398 000
France	FA	0	0%	0	0%	4 285 000
Export	FB	3 085 000	1100,4%	257 000	127,4%	113 000
Sale of goods produced	FF	1 378 205 000	29,6%	1 063 405 000	37,3%	774 240 000
France	FD	709 502 000	4,1%	681 377 000	-6,1%	726 007 000
Export	FE	668 703 000	75,0%	382 028 000	692,0%	48 233 000
Sale of services	FI	239 563 000	2,6%	233 601 000	-7,6%	252 729 000
France	FG	224 510 000	3,9%	216 175 000	-2,8%	222 376 000
Export	FH	15 053 000	-13,6%	17 426 000	-42,6%	30 353 000
Net turnover	FL	1 620 853 000	24,9%	1 297 263 000	25,8%	1 031 367 000
France	FJ	934 012 000	4,1%	897 552 000	-5,8%	952 668 000
Export	FK	686 841 000	71,8%	399 711 000	407,9%	78 699 000
Stocked production	FM	103 712 000	128,2%	45 447 000	108,7%	21 781 000
Self-constructed assets	FN	3 873 000	7,7%	3 596 000	28,8%	2 792 000
Operating grants	FO	526 000	42,2%	370 000	-13,3%	427 000
Release of reserves and provisions	FP	108 004 000	18,3%	91 325 000	13,5%	80 454 000
Other income	FQ	1 210 000	390,2%	-417 000	-111,6%	3 586 000

Operating charges (II)

			31/12/2010		31/12/2009		31/12/2008
	Total operating charges (Total II)	GF	1 895 953 000	35,7%	1 397 206 000	19,8%	1 166 265 000

Exploitation charges

		31/12/2010		31/12/2009		31/12/2008
Purchase of goods for resale	FS	114 000	107,3%	55 000	-98,8%	4 474 000
Change in stocks of goods for resale	FT	0	0%	245 000	12150,0%	2 000
Purchase of raw materials	FU	945 181 000	63,5%	578 269 000	80,2%	320 909 000
Change in stocks of raw materials	FV	19 809 000	349,2%	4 410 000	130,0%	-14 722 000
Other external purchases and charges	FW	247 815 000	-5,8%	262 999 000	13,3%	232 092 000
Tax, duty and similar payments	FX	36 799 000	-7,5%	39 794 000	8,1%	36 811 000
Payroll	FY	200 423 000	-0,1%	200 525 000	5,2%	190 671 000
Social security costs	FZ	114 288 000	2,8%	111 221 000	2,9%	108 135 000

Depreciation

		31/12/2010		31/12/2009		31/12/2008
Depreciation of fixed assets	GA	150 970 000	22,2%	123 525 000	4,0%	118 797 000
Amortisation of fixed assets	GB	10 254 000	-18,4%	12 572 000	0%	0
Depreciation/amortisation of current assets	GC	14 880 000	-51,8%	30 871 000	-16,4%	36 935 000
Provisions for risks and charges	GD	148 050 000	344,1%	33 339 000	-74,2%	129 140 000

Other charges

			31/12/2010		31/12/2009		31/12/2008
	Other charges	GE	7 370 000	1288,7%	-620 000	-120,5%	3 021 000

Operating charges (III-IV)

		31/12/2010		31/12/2009		31/12/2008
Share of joint-venture transferred to other partner(s) (Total III)	GH	6 328 000	55,7%	4 063 000	482,6%	-1 062 000
Share of joint venture transferred from other partner(s) (Total IV)	GI	0	0%	0	0%	0

Financial income (V)

		31/12/2010		31/12/2009		31/12/2008
Total financial income (Total V)	GP	9 251 000	79,8%	5 144 000	-15,1%	6 059 000
Share financial income	GJ	777 000	37,3%	566 000	-34,2%	860 000
Other investment income & capitalised receivables	GK	0	0%	0	0%	5 000
Other interest and similar income	GL	503 000	-33,0%	751 000	90,1%	395 000
Released provisions and transferred charges	GM	526 000	174,0%	192 000	-87,6%	1 554 000
Exchange gains	GN	7 445 000	104,9%	3 634 000	12,0%	3 246 000
Net income from disposal of investment securities	GO	0	0%	0	0%	0

Financial Charge (VI)

		31/12/2010		31/12/2009		31/12/2008
Total financial charge (Total VI)	GU	15 198 000	40,5%	10 817 000	38,7%	7 800 000
Financial reserves and provisions	GQ	5 075 000	-8,6%	5 554 000	281,5%	1 456 000
Interest and similar charges	GR	1 651 000	78,7%	924 000	-72,1%	3 310 000
Exchange losses	GS	8 472 000	95,3%	4 339 000	43,0%	3 034 000
Net loss from disposal of investment securities	GT	0	0%	0	0%	0

Financial Charge (VII)

		31/12/2010		31/12/2009		31/12/2008
Total extraordinary income (Total VII)	HD	24 464 000	-59,1%	59 760 000	27,8%	46 756 000
Extraordinary operating income	HA	150 000	1775,0%	8 000	-99,9%	12 212 000
Extraordinary income from capital transactions	HB	408 000	-3,1%	421 000	-66,0%	1 240 000
Released provisions and transferred charges	HC	23 906 000	-59,7%	59 331 000	78,1%	33 304 000

Extraordinary charges (VIII)

		31/12/2010		31/12/2009		31/12/2008
Total extraordinary charges (Total VIII)	HH	208 978 000	499,6%	34 850 000	-21,2%	44 236 000
Extraordinary operating charges	HE	25 000	316,7%	6 000	100%	3 000
Extraordinary charges from capital transactions	HF	23 000	-78,9%	109 000	-88,2%	923 000
Extraordinary reserves and provisions	HG	208 930 000	501,5%	34 735 000	-19,8%	43 310 000

Employee profit sharing (IX)

			31/12/2010		31/12/2009		31/12/2008
	Employee profit sharing (Total IX)	HJ	26 116 000	3,8%	25 164 000	-6,7%	26 965 000

Tax on profits (X)

31/12/2010

31/12/2009

31/12/2008

Tax on profits (Total X)

-11 009 000

33,9%

-16 665 000

17,5%

-20 212 000

References

		31/12/2010		31/12/2009		31/12/2008
Of which equipment leases	HP	0	0%	0	0%	0
Of which property leases	HQ	0	0%	0	0%	0
Of which transferred charges	A1	0	0%	0	0%	0
Of which trader's own contributions	A2	0	0%	0	0%	0
Of which royalties on licences and patents (income)	A3	0	0%	0	0%	0
Of which royalties on licences and patents (charges)	A4	0	0%	0	0%	0

Display parameter
Currency	Euro	Kilo Euro

Other incomer tax return forms
Reserve for depreciation | Provisions included in balance sheet | State deadlines claims and debts at the end of period
Table allocation results and other information

Fixed Assets
Grand Total Fixed Assets (I to IV)

		31/12/2010		31/12/2009		31/12/2008
Gross value at begin of period	OG	0	0%	0	0%	2 139 045 000
Increasess due to revaluation	OH	0	0%	0	0%	0
Decreasess, acquisitions, creations, contributions	OJ	0	0%	0	0%	230 850 000
Decreasess by budget item transfer	OK1	0	0%	0	0%	0
Decreasess by transfers	OK2	131 604 000	6,0%	124 120 000	-25,3%	166 197 000
Gross value at the end of period	OL	2 433 382 000	6,0%	2 294 732 000	4,1%	2 203 699 000

Research and development Charge (Total I)

		31/12/2010		31/12/2009		31/12/2008
Gross value at begin of period	CZ	0	0%	0	0%	0
Increasess due to revaluation	KB	0	0%	0	0%	0
Increasess, acquisitions, creations, contributions	KC	0	0%	0	0%	0
Decreasess by budget item transfer	C01	0	0%	0	0%	0
Decreasess by transfers	C02	0	0%	0	0%	0
Gross value at the end of period	D0	0	0%	0	0%	0

Other budget item from Intangible fixed assets (Total II)

		31/12/2010		31/12/2009		31/12/2008
Gross value at begin of period	KD	29 781 000	-1,3%	30 178 000	4,5%	28 887 000
Increasess due to revaluation	KE	0	0%	0	0%	0
Increasess, acquisitions, creations, contributions	KF	2 692 000	22,4%	2 199 000	-49,7%	4 372 000
Decreasess by budget item transfer	LV1	0	0%	0	0%	0
Decreasess by transfers	LV2	768 000	-70,4%	2 597 000	-15,7%	3 081 000
Gross value at the end of period	LW	31 705 000	6,5%	29 780 000	-1,3%	30 178 000

Tangible fixed assets (Total III)

		31/12/2010		31/12/2009		31/12/2008
Gross value at begin of period	LN	2 246 906 000	4,2%	2 156 275 000	2,6%	2 102 149 000
Increasess due to revaluation	LO	0	0%	0	0%	0
Increasess, acquisitions, creations, contributions	LP	266 176 000	26,0%	211 302 000	-0,4%	212 235 000
Decreasess by budget item transfer	NG1	0	0%	0	0%	0
Decreasess by transfers	NG2	128 869 000	6,8%	120 670 000	-23,7%	158 109 000
Gross value at the end of period	NH	2 384 213 000	6,1%	2 246 907 000	4,2%	2 156 275 000

Fiancial assets (Total IV)

		31/12/2010		31/12/2009		31/12/2008
Gross value at begin of period	LQ	18 044 000	4,6%	17 246 000	115,3%	8 009 000
Increasess due to revaluation	LR	0	0%	0	0%	0
Increasess, acquisitions, creations, contributions	LS	1 387 000	-16,0%	1 652 000	-88,4%	14 243 000
Decreasess by budget item transfer	NJ1	0	0%	0	0%	0
Decreasess by transfers	NJ2	1 967 000	130,3%	854 000	-82,9%	5 007 000
Gross value at the end of period	NK	17 464 000	-3,2%	18 044 000	4,6%	17 246 000

Reserve for depreciation
Situation and movement of reserve for depreciation
Grand total (I-II-III)

			31/12/2010		31/12/2009		31/12/2008
	Reserve for depreciation value at begin of period	0N	0	0%	0	0%	1 368 898 000
Increases		0P	0	0%	0	0%	137 613 000
Decreasess		0Q	0	0%	0	0%	60 925 000
	Reserve for depreciation value at the end of period	0R	0	0%	0	0%	1 445 586 000

Research and development charge (Total I)

			31/12/2010		31/12/2009		31/12/2008
	Reserve for depreciation value at begin of period	CY	0	0%	0	0%	0
Increases		PB	0	0%	0	0%	0
Decreasess		PC	0	0%	0	0%	0
	Decreasess by budget item transfer	PD	0	0%	0	0%	0

Other intangible assets (Total II)

			31/12/2010		31/12/2009		31/12/2008
	Reserve for depreciation value at begin of period	PE	25 055 000	6,3%	23 579 000	-5,2%	24 870 000
Increases		PF	1 283 000	-13,9%	1 490 000	-14,6%	1 744 000
Decreasess		PG	130 000	766,7%	15 000	-99,5%	3 035 000
	Decreasess by budget item transfer	PH	26 208 000	4,6%	25 055 000	6,3%	23 579 000

Total fixed assets amotisation (Total III)

			31/12/2010		31/12/2009		31/12/2008
	Reserve for depreciation value at begin of period	QU	1 503 327 000	8,0%	1 392 190 000	3,6%	1 344 028 000
Increases		QV	164 342 000	18,2%	139 008 000	2,3%	135 869 000
Decreases		QW	48 534 000	-16,0%	57 778 000	-0,2%	57 890 000
	Decreasess by budget item transfer	QX	1 619 135 000	9,9%	1 473 420 000	3,6%	1 422 007 000

Movements during period affecting charge allocated over several period
Charges à répartir ou frais d'émission d'emprunt

			31/12/2010		31/12/2009		31/12/2008
	Gross value at begin of period	Z91	0	0%	0	0%	0
Increases		Z92	0	0%	0	0%	0
Depreciation of fixed assets during period		Z9	0	0%	0	0%	0
	Decreasess by budget item transfer	B1	0	0%	0	0%	0

Premium refund of obligations

			31/12/2010		31/12/2009		31/12/2008
	Net value at begining of period	SP1	0	0%	0	0%	0
Increases		SP2	0	0%	0	0%	0
Depreciation of fixed assets during period		SP	0	0%	0	0%	0
	Net value at the end of period	SR	0	0%	0	0%	0

Provisions included in balance sheet
Grand Total (I-II-III)

			31/12/2010		31/12/2009		31/12/2008
	Value at begining of period	7C	645 243 000	-5,3%	681 176 000	16,3%	585 877 000
Increases		UB	380 012 000	230,7%	114 923 000	-44,0%	205 400 000
Decreases		UC	129 558 000	-14,1%	150 855 000	37,0%	110 101 000
	Value at the end of period	UD	895 697 000	38,8%	645 244 000	-5,3%	681 176 000

Includes Total allocations

Operating	UE	0%	33 339 000	-73,7%	126 851 000
Financial	UG	0%	5 553 000	281,4%	1 456 000
Exceptional	UJ	0%	4 455 000	1934,2%	219 000

Includes Total Withdrawal

Operating	UF	0%	35 167 000	-18,0%	42 898 000
Financial	UH	0%	188 000	889,5%	19 000
Exceptional	UK	0%	2 704 000	90033,3%	3 000

Total regulated provisions (Total I)

			31/12/2010		31/12/2009		31/12/2008
	Value at begining of period	3Z	186 644 000	0,9%	184 989 000	0,0%	184 925 000
Increases		TS	22 176 000	-14,1%	25 822 000	-9,5%	28 545 000
Decreases		TT	20 933 000	-13,4%	24 167 000	-15,1%	28 481 000
	Value at the end of period	TU	187 887 000	0,7%	186 644 000	0,9%	184 989 000

Total risk and charge provisions (Total II)

			31/12/2010		31/12/2009		31/12/2008
	Value at begining of period	5Z	290 790 000	1,9%	285 500 000	42,8%	199 895 000
Increases		TV	332 703 000	667,5%	43 348 000	-66,3%	128 525 000
Decreases		TW	49 091 000	29,0%	38 058 000	-11,3%	42 920 000
	Value at the end of period	TX	574 402 000	97,5%	290 790 000	1,9%	285 500 000

Total Provision for depreciation (Total III)

			31/12/2010		31/12/2009		31/12/2008
	Value at begining of period	7B	167 809 000	-20,4%	210 687 000	4,8%	201 057 000
Increases		TY	25 133 000	-45,1%	45 754 000	-5,3%	48 330 000
Decreases		TZ	59 534 000	-32,8%	88 631 000	129,0%	38 700 000
	Value at the end of period	UA	133 408 000	-20,5%	167 810 000	-20,4%	210 687 000

State deadlines claims and debts at the end of period
State claims

		31/12/2010		31/12/2009		31/12/2008
Gross value	VT	0	0%	0	0%	0
1 year at most	VU	0	0%	0	0%	0
More than one year	VV	0	0%	0	0%	0

State of loans

		31/12/2010		31/12/2009		31/12/2008
Claims related to holdings (gross)	UL	0	0%	0	0%	0
Claims related to shareholdings (1 year at most)	UM	0	0%	0	0%	0
Loans (gross)	UP	0	0%	0	0%	0
Loans (1 year at most)	UR	0	0%	0	0%	0
Other financial assets (gross)	UT	0	0%	0	0%	0
Other financial assets (1 year at most)	UV	0	0%	0	0%	0

Receivables statement of assets

		31/12/2010		31/12/2009		31/12/2008
Customers doubtful or disputed	VA	0	0%	0	0%	0
Other claims customer	UX	0	0%	0	0%	0
Receivables represent Loaned Securities	UU	0	0%	0	0%	0
Provision for depreciation previously established	UQ	0	0%	0	0%	0
Personnel and associated accounts	UY	0	0%	0	0%	0
Social Security and other social organizations	UZ	0	0%	0	0%	0
Income taxes	VM	0	0%	0	0%	0
Value added tax	VB	0	0%	0	0%	0
Other taxes and payments assimilated	VN	0	0%	0	0%	0
State and other public - Miscellaneous	VP	0	0%	0	0%	0
Group and Associates	VC	0	0%	0	0%	0
Accounts receivable (including claims relating to the operation of pension titles)	VR	0	0%	0	0%	0

Prepaid

			31/12/2010		31/12/2009		31/12/2008
	Prepaid	VS	0	0%	0	0%	0

State Debt

			31/12/2010		31/12/2009		31/12/2008
	Total debt (gross)	VY	0	0%	0	0%	0
1 year at most		VZ2	0	0%	0	0%	0
More than 1 year and 5 years at most		VZ3	0	0%	0	0%	0
More than 5 years		VZ4	0	0%	0	0%	0

Details

			31/12/2010		31/12/2009		31/12/2008
	Convertible bonds (gross)	7Y1	0	0%	0	0%	0
1 year at most		7Y2	0	0%	0	0%	0
More than 1 year and 5 years at most		7Y3	0	0%	0	0%	0
	Other bonds (gross)	7Z1	0	0%	0	0%	0
1 year at most		7Z2	0	0%	0	0%	0
More than 1 year and 5 years at most		7Z3	0	0%	0	0%	0
	Borrowing & debts to 1 year maximum at the origin (gross)	VG1	0	0%	0	0%	0
1 year at most		VG2	0	0%	0	0%	0
More than 1 year and 5 years at most		VG3	0	0%	0	0%	0
	Borrowing & debts to more than 1 year at the origin (gross)	VH1	0	0%	0	0%	0
1 year at most		VH2	0	0%	0	0%	0
More than 1 year and 5 years at most		VH3	0	0%	0	0%	0
	Loans and various financial liabilities (gross)	8A1	0	0%	0	0%	0
1 year at most		8A2	0	0%	0	0%	0
More than 1 year and 5 years at most		8A3	0	0%	0	0%	0
	Suppliers and associated accounts (gross)	8B1	0	0%	0	0%	0
1 year at most		8B2	0	0%	0	0%	0
More than 1 year and 5 years at most		8B3	0	0%	0	0%	0
	Personnel and associated accounts (gross)	8C1	0	0%	0	0%	0
1 year at most		8C2	0	0%	0	0%	0
More than 1 year and 5 years at most		8C3	0	0%	0	0%	0
	Social Security and other social organizations (gross)	8D1	0	0%	0	0%	0
1 year at most		8D2	0	0%	0	0%	0
More than 1 year and 5 years at most		8D3	0	0%	0	0%	0
	Taxes on profits (gross)	8E1	0	0%	0	0%	0
1 year at most		8E2	0	0%	0	0%	0
More than 1 year and 5 years at most		8E3	0	0%	0	0%	0
	VAT (gross)	VW1	0	0%	0	0%	0
1 year at most		VW2	0	0%	0	0%	0
More than 1 year and 5 years at most		VW3	0	0%	0	0%	0
	Backed Obligations (gross)	VX1	0	0%	0	0%	0
1 year at most		VX2	0	0%	0	0%	0
More than 1 year and 5 years at most		VX3	0	0%	0	0%	0
	Other taxes and assimilated (gross)	VQ1	0	0%	0	0%	0
1 year at most		VQ2	0	0%	0	0%	0
More than 1 year and 5 years at most		VQ3	0	0%	0	0%	0
	Assets and liabilities associated accounts (gross)	8J1	0	0%	0	0%	0
1 year at most		8J2	0	0%	0	0%	0
More than 1 year and 5 years at most		8J3	0	0%	0	0%	0
More than 5 years		8J4	0	0%	0	0%	0
	Groups and associates (gross)	VI1	0	0%	0	0%	0
1 year at most		VI2	0	0%	0	0%	0
More than 1 year and 5 years at most		VI3	0	0%	0	0%	0
More 5 years		VI4	0	0%	0	0%	0
	Other liabilities (gross)	8K1	0	0%	0	0%	0
1 year at most		8K2	0	0%	0	0%	0
More than 1 year and 5 years at most		8K3	0	0%	0	0%	0
	Debt representative of borrowed securities (gross)	SZ1	0	0%	0	0%	0
1 year at most		SZ2	0	0%	0	0%	0
More than 1 year and 5 years at most		SZ3	0	0%	0	0%	0
	Products in advance (gross)	8L1	0	0%	0	0%	0
1 year at most		8L2	0	0%	0	0%	0
More than 1 year and 5 years at most		8L3	0	0%	0	0%	0

References

		31/12/2010		31/12/2009		31/12/2008
Loans made during the period	VJ	0	0%	0	0%	0
Debt repaid during the period	VK	0	0%	0	0%	0

Table allocation results and other information
Dividends distributed

			31/12/2010		31/12/2009		31/12/2008
	Dividends	ZE	0	0%	0	0%	0

Commitments

		31/12/2010		31/12/2009		31/12/2008
Commitments leasing furniture	YQ	0	0%	0	0%	0
Commitments Real Estate Leasing	YR	0	0%	0	0%	0
Effects brought to the discount and unmatured	YS	0	0%	0	0%	0

Other charges Externes

		31/12/2010		31/12/2009		31/12/2008
Subcontracting	YT	0	0%	0	0%	0
Rentals, rental charges and condominiums	XQ	0	0%	0	0%	0
Staff outside the company	YU	0	0%	0	0%	0
Remuneration intermediaries and fees (excluding fees)	SS	0	0%	0	0%	0
Fees, commissions and brokerage	YV	0	0%	0	0%	0
Other accounts	ST	0	0%	0	0%	0
Total Other purchases and external	ZJ	0	0%	0	0%	0

Taxes and Fees

		31/12/2010		31/12/2009		31/12/2008
Business tax	YW	0	0%	0	0%	0
Other taxes and payments assimilated	9Z	0	0%	0	0%	0
Total taxes and fees	YX	0	0%	0	0%	0

VAT

		31/12/2010		31/12/2009		31/12/2008
Amount VAT collected	YY	0	0%	0	0%	0
Total VAT on goods and services	YZ	0	0%	0	0%	0

Average number of employees

			31/12/2010		31/12/2009		31/12/2008
	Average number of employees	YP	4 202	-1,2%	4 255	-0,1%	4 259

Groups and Shareholders

			31/12/2010		31/12/2009		31/12/2008
	Groups and Shareholders	ZR	0	-	0	-	-

Display parameter
Comparison mode	Average	Median

Ratios
Structure and liquidity | Management or rotation | Profitability of the business | Return on capital

Structure and Liquidity

	31/12/2010		31/12/2009		31/12/2008	Sector Median 2010
Fixed Asset Financing	1,32	0%	1,32	7,3%	1,23	1,33	-0,8%
Global Debt	151 days	3,4%	146 days	47,5%	99 days	168 days	-10,1%
Working Capital Fund overall net	173 days	-16,0%	206 days	18,4%	174 days	123 days	40,7%
Financial independence	143518,66%	-72,1%	513676,92%	41,4%	363363,08%	3245,83%	4321,6%
More ratios
Solvability	34,49%	-37,4%	55,11%	-11,5%	62,30%	52,49%	-34,3%
Capacity debt futures	%	-	%	-	%	30978%	-
Coverage of current assets by net working capital overall	69,22%	-2,2%	70,75%	27,1%	55,67%	57,73%	19,9%
General Liquidity		-		-		0,87	-
Restricted Liquidity		-		-		1,29	-

Management or rotation

	31/12/2010		31/12/2009		31/12/2008	Sector Median 2010
Need background in operating working capital	173 days	-15,6%	205 days	18,5%	173 days	62 days	179,0%
Treasury	0 days	0%	0 days	0%	1 days	14 days	0%
Inventory turnover of goods	0 days	0%	657572 days	0%	0 days	0 days	0%
Average length of credit granted to customers	85 days	-29,2%	120 days	71,4%	70 days	78 days	9,0%
Average length of credit obtained suppliers	54 days	-20,6%	68 days	-20,9%	86 days	87 days	-37,9%
More ratios
Inventory turnover of raw materials in industrial enterprises	0 days	0%	0 days	0%	141 days	85 days	0%
Inventory turnover of intermediate and finished products in the industrial enterprise	68 days	17,2%	58 days	20,8%	48 days	170 days	-60,0%
Rotation tangible assets	67,98%	17,7%	57,74%	20,7%	47,83%	224,69%	-69,7%

Profitability of the business

31/12/2010

31/12/2009

31/12/2008

Sector Median 2010

Margin trading

0,18%

-0,01

Profitability of the business

10,15

-11,7%

11,50

-33,4%

17,26

11,26%

-9,9%

Net profit

-15,86%

-473,2%

4,25%

233,2%

-3,19%

7,54%

-310,3%

More ratios

Growth rate of turnover (excluding VAT)

24,94%

-3,3%

25,78%

4066,2%

-0,65%

8,84%

182,1%

Rates integration

31,81%

-17,5%

38,57%

-22,5%

49,76%

40,05%

-20,6%

Rate leasing furniture

Work Factor

61,05%

-2,0%

62,31%

7,0%

58,23%

51,81%

17,8%

Weight interests

0,94

13,3%

0,83%

9,2%

0,76%

0,70%

34,3%

Return on capital

	31/12/2010		31/12/2009		31/12/2008	Sector Median 2010
Cash flow from the overall profitability	7,27%	-51,2%	14,89%	75,6%	8,48%	12,19%	-40,4%
Rates of economic profitability	17%	41,7%	12%	-33,3%	18%	11%	54,5%
Financial profitability	661621000%	-33,9%	1001670000%	6,0%	944744000%	718442%	91991,1%
Return on investment	-24,33%	-548,9%	5,42%	310,1%	-2,58%	8,94%	-372,1%

Display parameter
Currency	Euro	Kilo Euro
Comparison mode	Average	Median

Soldes Intermédiaires de Gestion

	31/12/2010				31/12/2009				31/12/2008			Sector Median 2010
Turnover	1 620 853 000			24,9%	1 297 263 000			25,8%	1 031 367 000			2 016 615 €	80274,9%
Sales of goods		3 085 000	1100,4%			257 000	-94,2%			4 398 000
- Purchase of goods		114 000	107,3%			55 000	-98,8%			4 474 000
+/- Stock of goods variation		0	0%			245 000	12150,0%			2 000
Trading margin		2 971 000 €	7009,3%			-43 000 €	44,9%			-78 000 €	0 €			0%
		0,18 % CA	0%			0,00 % CA	0%			-0,01 % CA	0 % CA			0%

Sale of goods produced	1 617 768 000	24,7%	1 297 006 000	26,3%	1 026 969 000
+/- Stocked production	103 712 000	128,2%	45 447 000	108,7%	21 781 000
+ Self-constructed assets	3 873 000	7,7%	3 596 000	28,8%	2 792 000
Period production	1 725 353 000 €	28,2%	1 346 049 000 €	28,0%	1 051 542 000 €	1 880 690 €	91640,4%
	106,45 % CA	2,6%	103,76 % CA	1,8%	101,96 % CA	100 % CA	6,4%

Trading margin

2 971 000

7009,3%

-43 000

44,9%

-78 000

+ Period Production	1 725 353 000	28,2%	1 346 049 000	28,0%	1 051 542 000	1 880 690	91640,4%
- Purchase of raw materials	945 181 000	63,5%	578 269 000	80,2%	320 909 000
+/- Change in stocks of raw materiels	19 809 000	349,2%	4 410 000	130,0%	-14 722 000
- Other external purchases and charges	247 815 000	-5,8%	262 999 000	13,3%	232 092 000
Added value	515 519 000 €	3,0%	500 328 000 €	-2,5%	513 185 000 €	780 803 €	65924,2%
	31,81 % CA	-17,5%	38,57 % CA	-22,5%	49,76 % CA	40,05 % CA	-20,6%

Added value	515 519 000 €	3,0%	500 328 000 €	-2,5%	513 185 000 €	780 803 €	65924,2%
+ Operating grants	526 000	42,2%	370 000	-13,3%	427 000
- Tax, duty and similar payments	36 799 000	-7,5%	39 794 000	8,1%	36 811 000
- Personal charges	314 711 000	1,0%	311 746 000	4,3%	298 806 000
Gross operating surplus	164 535 000 €	10,3%	149 158 000 €	-16,2%	177 995 000 €	155 816 €	105495,7%
	10,15 % CA	-11,7%	11,50 % CA	-33,4%	17,26 % CA	11,26 % CA	-9,9%

Gross operating surplus	164 535 000 €	10,3%	149 158 000 €	-16,2%	177 995 000 €	155 816 €	105495,7%
+ Release of reserves and provisions	108 004 000	18,3%	91 325 000	13,5%	80 454 000
+ Other operating income	1 210 000	390,2%	-417 000	-111,6%	3 586 000
- Depreciation/Amortisation	324 154 000	61,8%	200 307 000	-29,7%	284 872 000
- Other charges	7 370 000	1288,7%	-620 000	-120,5%	3 021 000
Operating result	-57 775 000 €	-243,1%	40 379 000 €	256,2%	-25 858 000 €	37 991 €	-152175,5%
	-3,56 % CA	-214,5%	3,11 % CA	223,9%	-2,51 % CA	6,70 % CA	-153,1%

Operating result	-57 775 000 €	-243,1%	40 379 000 €	256,2%	-25 858 000 €	37 991 €	-152175,5%
+/- Result of joint-venture transferred from/to other partners	6 328 000	55,7%	4 063 000	482,6%	-1 062 000
+ Financial income	9 251 000	79,8%	5 144 000	-15,1%	6 059 000
- Financial charges	15 198 000	40,5%	10 817 000	38,7%	7 800 000
Pre-tax result	-70 050 000 €	-328,6%	30 643 000 €	215,5%	-26 537 000 €	37 991 €	-184485,8%
	-4,32 % CA	-283,1%	2,36 % CA	191,8%	-2,57 % CA	6,83 % CA	-163,3%

Extraordinary income	24 464 000	-59,1%	59 760 000	27,8%	46 756 000	3 680	664682,6%
- Extraordinary charges	208 978 000	499,6%	34 850 000	-21,2%	44 236 000
Extraordinary result	-184 514 000 €	-840,7%	24 910 000 €	888,5%	2 520 000 €	-14 €	-1317957042,9%
	-11,38 % CA	-692,7%	1,92 % CA	700%	0 % CA	-00,03 % CA	-37833,3%

Pre-tax result	-70 050 000 €	-328,6%	30 643 000 €	215,5%	-26 537 000 €	37 991 €	-184485,8%
Extraordinary result	-184 514 000 €	-840,7%	24 910 000 €	888,5%	2 520 000 €	-14 €	-1317957042,9%
- Employee profit sharing	26 116 000	3,8%	25 164 000	-6,7%	26 965 000
- Tax on profits	-11 009 000	33,9%	-16 665 000	17,5%	-20 212 000
Net result	-269 671 000 €	-673,1%	47 054 000 €	252,9%	-30 770 000 €	57 556 €	-468636,7%
	-16,64 % CA	-558,4%	3,63 % CA	221,8%	-2,98 % CA	7,62 % CA	-318,4%

FOREIGN EXCHANGE RATES

ADDITIONAL INFORMATION

Current Directors

Trading to Date	12/31/2010	12/31/2009	12/31/2008
Turnover	1,620,853,000 €	1,297,263,000 €	1,031,367,000 €
Gross Operating Surplus	10,15 % Turnover	11,50 % Turnover	17,26 % Turnover
Net worth	661,621,000 €	1,001,670,000 €	944,744,000 €
Employees	2 000 to 4 999 employees	-	-

Social security, pension funds preferential rights | Tax office preferential rights

Preferential rights details and history

Summary of preferential rights

Company monitored since

04/10/2007

Status of Monitoring

No social security and tax office preferential right to date

event history

Status history

Date	Description
No Status History

Recent publications in Gazettes

Publication date	Gazette Name	Description
07/02/2012	Bodacc B	Modification et mutation diverse

94 - VAL-DE-MARNE GREFFE DU TRIBUNAL DE COMMERCE DE CRÉTEIL 2035 - 428 706 204 RCS Créteil. SANOFI CHIMIE. Forme : Société anonyme. Administration : Administrateur : SANOFI WINTHROP INDUSTRIE représenté par LUSCAN Philippe modification le 29 Décembre 2011 Administrateur : SANOFI-AVENTIS PARTICIPATIONS représenté par TOURATIER Gérard modification le 25 Juin 2010 Directeur général délégué : CAYRON Marie-Claire modification le 25 Juin 2010 Président directeur général et administrateur : CARRE Francis modification le 25 Juin 2010 Administrateur : SANOFI-AVENTIS GROUPE représenté par LHERNOULD Gilles modification le 25 Juin 2010 Commissaire aux comptes suppléant : AUDITEX en fonction le 26 Mai 2011 Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT en fonction le 26 Mai 2011 Directeur général délégué : BROM Jacques en fonction le 30 Janvier 2012. Activité : . Commentaires : Modification de représentant.
25/01/2012	JAL	Appointment of the social representative

Petites affiches (Les) - La Loi - Le Quotidien juridique - archives commerciales de la France Date de décision : 13/01/2012 Société faisant l'objet d'une nomination : 428706204 - SANOFI CHIMIE, 9 RUE DU PDT SALVADOR ALLENDE, 94250 GENTILLY Nominé : Monsieur Jacques BROM, 94250 GENTILLY
25/01/2012	JAL	Resignation / Revocation of the social representative

Petites affiches (Les) - La Loi - Le Quotidien juridique - archives commerciales de la France Date de décision : 13/01/2012 La société 428706204 - SANOFI CHIMIE, 9 RUE DU PDT SALVADOR ALLENDE, 94250 GENTILLY Fait l'objet du départ de Monsieur Dominique EVEN
23/06/2011	Bodacc C	Comptes annuels et rapports

94 - VAL-DE-MARNE GREFFE DU TRIBUNAL DE COMMERCE DE CRÉTEIL 10623 - 428706204 RCS. SANOFI CHIMIE. Forme : Société anonyme. Adresse : 9 rue du Président S. Allendé 94250 Gentilly. Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2010.
05/06/2011	Bodacc B	Modification et mutation diverse

94 - VAL-DE-MARNE GREFFE DU TRIBUNAL DE COMMERCE DE CRÉTEIL 1113 - 428 706 204 RCS Créteil. SANOFI CHIMIE. Forme : Société anonyme. Administration : Administrateur : SANOFI WINTHROP INDUSTRIE représenté par LUSCAN Philippe modification le 25 Juin 2010 Directeur général délégué : EVEN Dominique modification le 25 Juin 2010 Administrateur : SANOFI-AVENTIS PARTICIPATIONS représenté par TOURATIER Gérard modification le 25 Juin 2010 Directeur général délégué : CAYRON Marie-Claire modification le 25 Juin 2010 Président directeur général et administrateur : CARRE Francis modification le 25 Juin 2010 Administrateur : SANOFI-AVENTIS GROUPE représenté par LHERNOULD Gilles modification le 25 Juin 2010 Commissaire aux comptes suppléant : AUDITEX en fonction le 26 Mai 2011 Commissaire aux comptes titulaire : ERNST & YOUNG AUDIT en fonction le 26 Mai 2011. Activité : . Commentaires : Modification de représentant.
09/07/2010	Bodacc C	Comptes annuels et rapports

94 - VAL-DE-MARNE GREFFE DU TRIBUNAL DE COMMERCE DE CRÉTEIL 9896 - 428706204 RCS. SANOFI CHIMIE. Forme : Société anonyme. Adresse : 9 rue du Président S. Allendé 94250 Gentilly. Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2009.
01/07/2009	Bodacc C	Comptes annuels et rapports

94 - VAL-DE-MARNE GREFFE DU TRIBUNAL DE COMMERCE DE CRETEIL 12137 - 428706204 RCS. SANOFI CHIMIE. Forme : Société anonyme. Adresse : 9 rue du Président S. Allendé 94250 Gentilly. Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2008.
09/10/2008	Bodacc B	Modification et mutation diverse

94 - VAL-DE-MARNE GREFFE DU TRIBUNAL DE COMMERCE DE CRETEIL 4546 - 428 706 204 RCS Créteil. SANOFI CHIMIE. Forme : Société anonyme. Administration : Administrateur : SANOFI WINTHROP INDUSTRIE représenté par LUSCAN Philippe modification le 29 Septembre 2008. Commissaire aux comptes titulaire : PRICEWATERHOUSECOOPERS AUDIT SA modification le 22 Mars 2006. Directeur général délégué : EVEN Dominique en fonction le 04 Mai 2005. Commissaire aux comptes suppléant : NICOLAS Yves modification le 22 Mars 2006. Administrateur : SANOFI-AVENTIS PARTICIPATIONS représenté par TOURATIER Gérard en fonction le 03 Juillet 2006. Directeur général délégué : CAYRON Marie-Claire en fonction le 28 Février 2007. Président directeur général et administrateur : CARRE Francis en fonction le 29 Septembre 2008. Administrateur : SANOFI-AVENTIS GROUPE représenté par LHERNOULD Gilles en fonction le 29 Septembre 2008. Commentaires : Modification de représentant.
30/06/2008	Bodacc C	Comptes annuels et rapports

94 - VAL-DE-MARNE GREFFE DU TRIBUNAL DE COMMERCE DE CRETEIL 9178 - 428706204 RCS. SANOFI CHIMIE. Forme : Société anonyme. Adresse : 9 rue du Président S. Allendé 94250 Gentilly. Commentaires : Comptes annuels et rapports de l'exercice clos le : 31/12/2007.
18/07/2007	Bodacc C	Avis de dépôt des comptes

6625 - 428 706 204. RCS Créteil SANOFI CHIMIE. Forme: Société anonyme. Adresse du siège social: 9 rue du Président S. Allendé 94250 Gentilly. Comptes annuels et rapports de l'exercice clos le: 31 décembre 2006.
21/03/2007	Bodacc B	Modifications et mutations diverses

3032 - RCS Créteil B 428 706 204. RC 02-B 573. SANOFI CHIMIE. Forme : S.A. Commentaires : modification survenue sur l'administration. Administration : nomination d'un directeur général délégué : CAYRON (Marie-Claire) (Nom d'usage : DUPONT-CAYRON).
22/02/2007	Bodacc B	Modifications et mutations diverses

2912 - RCS Créteil B 428 706 204. RC 02-B 573. SANOFI CHIMIE. Forme : S.A. Capital : 524 786 320 euros. Commentaires : modification survenue sur le capital (augmentation).
20/10/2006	Bodacc B	Modifications et mutations diverses

1728 - RCS Créteil B 428 706 204. RC 02-B 573. SANOFI CHIMIE. Forme : S.A. Commentaires : modification survenue sur l'administration. Administration : administrateur partant : RAMET (Alain, René). Nomination du président du conseil d'administration et directeur général : LUSCAN (Philippe).
02/08/2006	Bodacc B	Modifications et mutations diverses

3192 - RCS Créteil B 428 706 204. RC 02-B 573. SANOFI CHIMIE. Forme : S.A. Commentaires : modification survenue sur l'administration. Administration : administrateur partant : SANOFI AVENTIS S.A., représentée par TOURATIER (Gérard). Nomination d'un administrateur : SANOFI-AVENTIS PARTICIPATIONS, représentée par TOURATIER (Gérard).
21/07/2006	Bodacc C	Avis de dépôt des comptes

3498 - RCS Créteil B 428 706 204. RC 02-B 573. SANOFI CHIMIE. Forme: S.A. Adresse du siège social: 9, rue du Président S Allende,94250 Gentilly. Comptes annuels et rapports de l'exercice clos le: 31 décembre 2005.
23/07/2005	Bodacc C	Avis de dépôt des comptes

3250 - RCS Créteil B 428 706 204. RC 02-B 573. SANOFI CHIMIE. Forme: S.A. Adresse du siège social: 9, rue du Président S Allende,94250 Gentilly. Comptes annuels et rapports de l'exercice clos le: 31 décembre 2004.
30/06/2005	Bodacc B	Modifications et mutations diverses

2249 - RCS Créteil B 428 706 204. RC 02-B 573. SANOFI CHIMIE. Forme : S.A. Commentaires : modification survenue sur l'administration. Administration : commissaire aux comptes suppléant partant : TELLIER (Liliane). Nomination d'un commissaire aux comptes suppléant : NICOLAS (Yves).
27/05/2005	Bodacc B	Modifications et mutations diverses

3370 - RCS Créteil B 428 706 204. RC 02-B 573. SANOFI CHIMIE. Forme : S.A. Commentaires : modification survenue sur l'administration. Administration : modification d'un commissaire aux comptes titulaire : BEFEC-PRICEWATERHOUSE AUDIT S.A. Nomination d'un directeur général délégué : EVEN (Dominique).
27/03/2005	Bodacc A	Vente et cession

985 - RCS Versailles 410 352 777. GLAXO WELLCOME PRODUCTION. Forme : S.A.S. Adresse du siège social : 100 route de Versailles, 78160 Marly-le-Roi. GLAXO GROUP LIMITED. Forme : société de droit anglais. Adresse du siège social : Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex (Grande-Bretagne). Etablissement secondaire - Activité : préparation, fabrication, répartition, conditionnement, distribution de produits pharmaceutiques et préparation de principes actifs. Adresse : 1 rue de l'Abbaye, 76960 Notre-Dame-de-Bondeville. Etablissement secondaire acquis par achat au prix stipulé de 103 100 664,65 euros. Date de début d'activité : 1er septembre 2004. Précédents propriétaires : SANOFI WINTHROP INDUSTRIE. RCS 775 662 257. RC 88-B 164. SANOFI CHIMIE. RCS Créteil 428 706 204. RC 02-B 197. SANOFI AVENTIS. RCS Paris 395 030 844. Publication légale : Paris-Normandie du 10 janvier 2005. Oppositions : au fonds.
18/07/2002	Bodacc B	Modifications et mutations diverses

RCS Créteil B 428706204 RC 02-B 573 SANOFI CHIMIE. Forme : S.A. Commentaires : modification survenue sur l' administration. Administration : modification du président du conseil d' administration et directeur général : RAMET (Alain, René).
25/06/2002	Bodacc A	Création d'établissement

RCS B 428706204 RC 02-B 341 SANOFI CHIMIE. Forme : S.A. Capital : 270 762 670 euros. Adresse du siège social : 9 rue du Président-Salvador-Allende, 94250 Gentilly Etablissement principal: Activité : fabrication de produits de base pour l'industrie pharmaceutique. Adresse : route d'Avignon, 30390 Aramon Etablissement principal acquis par apport au montant évalué à 406 084 000 euros Date de début d'activité: 31 décembre 2001. Précédent propriétaire : SANOFI CHIMIE Publication légale: Les Petites affiches du 30 janvier 2002 déclaration de créances: au tribunal de commerce de Nimes.
18/06/2002	Bodacc A	Création d'établissement

RCS Evry B 428706204 RC 02-B 1191 SANOFI CHIMIE. Forme : S.A. Adresse du siège social : 9 rue du Président- Salvador-Allende, 94250 Gentilly ETABLISSEMENT SECONDAIRE. Activité : fabrication et exploitation de produits chimiques à usage pharmaceutique. Adresse : La Grange Saint-Clair, Pecqueuse, 91470 Limours Etablissement secondaire acquis par apport au montant évalué à 406 084 000 euros Date de début d'activité: 31 décembre 2001. Précédent propriétaire : SASY 3. RCS 592032874 Publication légale: Les Petites affiches du 30 janvier 2002 déclaration de créances: au tribunal de commerce d'Evry.
12/03/2002	Bodacc B	Modifications et mutations diverses

RCS Créteil B 428706204 RC 02-B 573 SANOFI CHIMIE. Forme : S.A. Commentaires : cessation d'activité.
07/03/2002	Bodacc B	Modifications et mutations diverses

RCS Créteil B 428706204 RC 02-B 573 SANOFI CHIMIE. Forme : S.A. Capital : 270 762 670 euros. Activité : fabrication de produits de base pour l'industrie pharmaceutique. Adresse du siège social : 9 rue du Président-Salvador-Allende, 94250 Gentilly. Administration : P.-D.G. : RAMET (Alain, René). Administrateurs : SANOFI WINTHROP INDUSTRIE, représentée par LHERNOULD (Gilles, Albert, Raymond) SANOFI-SYNTHELABO RECHERCHE, représentée par AUBLET (Yves, Pascal, Bernard). Commissaire aux comptes titulaire : BEFEC-PRICEWATERHOUSE. Commissaire aux comptes suppléant : TELLIER (Liliane). Commentaires : cette société transfère son siège du 174 avenue de France, 75013 Paris. Date d'effet : 31 décembre 2001.
11/09/2001	Bodacc B	Modifications et mutations diverses

RCS Paris B 428706204 RC 99-B 19509 SASY 1. Forme : S.A. Commentaires : modification survenue sur l' administration. Administration : président du conseil d'administration partant : LAIMAY, née BERTHOU (Marie- Hélène). Nomination du président du conseil d'administration : MULLIEZ ( Christian). Modification du commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT S.A. Modification du commissaire aux comptes suppléant : CARREGA ( François).
09/01/2000	Bodacc A	Création d'établissement

RCS Paris B 428706204 RC 99-B 19509 SASY 1. Forme : S.A. Capital : 40 000 euros. Activité : prise de participations et fourniture de prestations de services. Adresse du siège social : 174 avenue de France, 75013 Paris. Administration : président du conseil d'administration : LAIMAY, née BERTHOU (Marie-Hélène). Administrateurs : RENARD (Jean-Luc) SANOFI SYNTHELABO S.A., représentée par DEBROUX, née SIOUFFI (Laurence) SECIPE S.A., représentée par LEROY ( Jean, Claude). Commissaire aux comptes titulaire : ERNST ET YOUNG AUDIT. Commissaire aux comptes suppléant : CARREGA (François) Cette société se constitue Date de début d'activité: 13 décembre 1999

Company events history

Date	Description
07/02/2012	Bodacc B: Various editing or changing
30/01/2012	Minutes of Board meeting
30/01/2012	Changes to the Board of Directors
25/01/2012	Legal Gazette: Resignation / Revocation of the social representative
13/01/2012	Legal Gazette: Appointment of the social representative
31/12/2011	Update of Company Workforce
31/12/2011	Closure of Establishment
23/06/2011	Bodacc C : Deposit accounts notice
16/06/2011	Consideration of a balance sheet that has led to a reassessment of this company's creditworthiness
05/06/2011	Bodacc B: Various editing or changing
26/05/2011	New auditor
31/12/2010	New accounts available
03/09/2010	New subsidiarie(s) detected
09/07/2010	Bodacc C : Deposit accounts notice
31/12/2009	New accounts available
01/07/2009	Bodacc C : Deposit accounts notice
31/12/2008	New accounts available
09/10/2008	Bodacc B: Various editing or changing
09/10/2008	New Bodacc B ads detected
29/09/2008	New chairman (CEO, CoB)
29/09/2008	Modification du Conseil d'Administration
29/09/2008	Amendment
29/09/2008	Acte modificatif
29/09/2008	Power of attorney
29/09/2008	Changes to the Board of Directors
29/09/2008	Minutes of Board meeting
29/09/2008	Appointment/resignation of company officers
29/09/2008	Private document
29/09/2008	Nomination/démission des organes de gestion
29/09/2008	Changement de Président (PDG, PCA)
30/06/2008	Bodacc C : Deposit accounts notice
31/12/2007	New accounts available
04/10/2007	Collection of preferential rights activated for this company
28/02/2007	Private document
28/02/2007	Minutes of Board meeting
28/02/2007	Modification du Conseil d'Administration
28/02/2007	Appointment/resignation of company officers
08/02/2007	Fusion
08/02/2007	Augmentation de Capital
08/02/2007	Capital increase
08/02/2007	Private document
08/02/2007	Déclaration de conformité
08/02/2007	Declaration of conformity
08/02/2007	PV d'Assemblée
08/02/2007	Minutes of general meeting of shareholders
08/02/2007	Minutes of Board meeting
08/02/2007	Statuts mis à jour
08/02/2007	Updated articles of association
08/02/2007	Acte modificatif
08/02/2007	Amendment
31/12/2006	New accounts available
14/12/2006	Audit or Management Report
14/12/2006	Private document
14/12/2006	Rapport des Commissaires ou du Gérant
21/11/2006	Amendment
21/11/2006	Projet de Fusion
21/11/2006	Planned merger
21/11/2006	Private document
10/10/2006	Minutes of Board meeting
10/10/2006	Changement de Président (PDG, PCA)
10/10/2006	Modification du Conseil d'Administration
10/10/2006	Changes to the Board of Directors
10/10/2006	Private document
10/10/2006	Appointment/resignation of company officers
04/07/2006	Requête et Ordonnance
03/07/2006	Appointment/resignation of company officers
03/07/2006	Nomination/démission des organes de gestion
03/07/2006	Modification du Conseil d'Administration
03/07/2006	Minutes of general meeting of shareholders
03/07/2006	Private document
26/06/2006	Application and court order
07/03/2006	Nomination/démission des organes de gestion
07/03/2006	Amendment
07/03/2006	Acte modificatif
07/03/2006	Private document
31/12/2005	New accounts available
14/06/2005	Private document
14/06/2005	Acte sous seing privé
14/06/2005	Minutes of general meeting of shareholders
14/06/2005	Changement de Commissaire aux Comptes
14/06/2005	Nomination/démission des organes de gestion
14/06/2005	Appointment/resignation of company officers
14/06/2005	PV d'Assemblée
04/05/2005	Private document
04/05/2005	Acte sous seing privé
04/05/2005	Modification du Conseil d'Administration
04/05/2005	Minutes of Board meeting
04/05/2005	PV du Conseil d'Administration
04/05/2005	Nomination/démission des organes de gestion
04/05/2005	Appointment/resignation of company officers
04/03/2005	Acte sous seing privé
04/03/2005	Private document
04/03/2005	Acte modificatif
04/03/2005	Amendment
04/03/2005	Nomination/démission des organes de gestion
31/12/2004	New accounts available
07/06/2004	Updated articles of association
07/06/2004	Acte modificatif
07/06/2004	Amendment
07/06/2004	PV d'Assemblée
07/06/2004	Acte sous seing privé
07/06/2004	Private document
07/06/2004	Minutes of general meeting of shareholders
07/06/2004	Statuts mis à jour
31/12/2003	New accounts available
14/03/2003	Nomination/démission des organes de gestion
14/03/2003	Acte sous seing privé
14/03/2003	Acte modificatif
05/07/2002	Statuts mis à jour
05/07/2002	PV d'Assemblée
05/07/2002	Nomination/démission des organes de gestion
05/07/2002	Acte sous seing privé
05/07/2002	Modification du Conseil d'Administration
05/07/2002	Changement de Président (PDG, PCA)
05/07/2002	PV du Conseil d'Administration
22/02/2002	Immatriculation suite à transfert
22/02/2002	Statuts mis à jour
22/02/2002	Changement de Président (PDG, PCA)
22/02/2002	Nomination/démission des organes de gestion
22/02/2002	Modification du Conseil d'Administration
22/02/2002	PV du Conseil d'Administration
22/02/2002	Acte sous seing privé
22/02/2002	PV d'Assemblée
22/02/2002	Modification de l'objet social
22/02/2002	Augmentation de Capital
22/02/2002	Apport Partiel
22/02/2002	Acte modificatif
22/02/2002	Changement de Commissaire aux Comptes
22/02/2002	Déclaration de conformité
22/02/2002	Changement de dénomination sociale
20/12/2001	Acte sous seing privé
20/12/2001	Rapport des Commissaires ou du Gérant
30/11/2001	Apport Partiel
30/11/2001	Acte sous seing privé
30/11/2001	Acte modificatif
29/10/2001	Requête et Ordonnance
27/08/2001	Nomination/démission des organes de gestion
27/08/2001	Acte sous seing privé
27/08/2001	PV du Conseil d'Administration
27/08/2001	Changement de Président (PDG, PCA)
27/08/2001	Modification du Conseil d'Administration
22/12/1999	Formation de Société
22/12/1999	Acte sous seing privé
22/12/1999	Statuts
22/12/1999	Nomination/démission des organes de gestion
22/12/1999	PV du Conseil d'Administration
22/12/1999	Certificat de dépôt des fonds

Establishment events history

Date	Description
07/01/2012	Update Rating
31/12/2011	Modification of Head office
31/12/2011	Update of Establishment Workforce
08/10/2011	Update Rating
07/10/2011	Update Rating
28/06/2011	Update of phone numbers
16/06/2011	Update Rating
06/05/2011	Update Rating
21/01/2011	Update Rating
03/09/2010	Update Rating
29/12/2009	Update Rating
04/08/2008	Update Rating
28/04/2008	Update Rating
09/12/2007	Update Limit
24/07/2007	Update Rating

NOTES & COMMENTS

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.53.34
UK Pound	1	Rs.86.11
Euro	1	Rs.69.07

INFORMATION DETAILS

Report Prepared by :

MNL

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
----	NB	New Business	----

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.

MIRA INFORM REPORT

REGISTERED NAME & COMPANY SUMMARY

DIRECTORS/MANAGEMENT

NEGATIVE INFORMATION

SHARE & SHARE CAPITAL INFORMATION

PAYMENT INFORMATION

GROUP STRUCTURE & AFFILIATED COMPANIES

FINANCIAL INFORMATION

FOREIGN EXCHANGE RATES

ADDITIONAL INFORMATION

NOTES & COMMENTS

Unit